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Overall abstract for thesis portfolio 
Objective: The thesis portfolio aimed to assess the psychometric properties and conceptual 
structure of rating scale measures of frontal functions. 
Methods: A systematic review of the literature collected data on the validity and reliability 
of executive function rating scales with various clinical and non-clinical groups.  
Alongside this, a validation study explored the psychometric properties of the revised 
dysexecutive questionnaire (DEX-R) in a non-clinical population. In total, 140 participants 
took part, some completing the DEX-R at two different timepoints and another validated 
measure, the FrSBe. Factor analysis and Rasch analysis were used to explore underlying 
subconstructs. Correlations of mood and demographic variables were also conducted.  
Results: There were 24 studies which met criteria for the systematic review. Papers used a 
variety of EF rating scales across different clinical and non-clinical groups. The DEX was 
the most widely used measure. Quality varied, many papers would have benefited from the 
use of a reference standard. In the empirical paper, the DEX-R was found to be a valid and 
reliable measure of dysexecutive problems in a non-clinical sample. It was determined to 
be multidimensional and a factor analysis resulted in three factors. Responses correlated 
with age and brief measures of anxiety and depression.  
Conclusions: Rating scale measures supplement neuropsychological testing well in their 
ecological validity and in capturing the wide-ranging difficulties individuals may face. 
Understanding individual differences has clinical benefits for interpreting assessments, 
particularly in variation of responses influenced somewhat by age and mood. Establishing 
robust sub-scales that map onto models may have useful clinical applications to understand 
specific areas of strength and limitations relevant for rehabilitation or adapting 
psychological therapies.  
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Introduction to the thesis portfolio 
This thesis portfolio includes two papers, a systematic review and an empirical 
research study. These both investigate psychometric properties of rating scales measuring 
frontal functions of the brain.  
What are frontal functions? 
The term ‘frontal functions’ encompasses cognitive, behavioural and emotional 
processes thought to originate in the frontal areas of the brain. These include flexible 
thinking, planning, monitoring, social behaviour, decision making, initiation, inhibition 
and emotional regulation (Lezak, 1995). The frontal areas of the brain have been 
implicated in neurological, developmental and mental health difficulties (Bombois et al., 
2007; Cullen, 2016; Hill, 2004; Morice & Delahunty, 1996; Swanberg, Tractenberg, Mohs, 
Thal & Cummings, 2004; Zinn, Bosworth, Hoenig & Swartzwelder, 2007). There can be 
profound functional difficulties which people can face as a result which vary from person 
to person, impacting upon activities of daily living, occupational and educational activities 
(Drakopoulos, Sparding, Clements, Pålsson, & Landén, 2020; Goel, Grafman, Tajik, Gana,  
& Danto, 1997; Grant & Adams, 2009; Laakso et al., 2019; Ponsford, Draper  & 
Schönberger, 2008; Vaughan & Giovanello, 2010). Different theoretical models have been 
proposed to account for the kinds of problems observed in people with acquired damage to 
the frontal areas of the brain. There have been several synonymous terms used 
interchangeably in attempting to define these as a psychological construct, including 
frontal functions, executive function and dysexecutive problems.  
Theories and models of frontal functions 
 Hierarchical models of frontal functions 
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Hierarchical views formed the early understanding of the functions of the frontal 
areas of the brain, proposing these control and regulate other lower-level cognitive 
processes (Lezak, 1982; Luria, 1995).  Initial theoretical frameworks suggested a unitary 
process involved in attentional control of these processes, known as a single central 
executive (Baddeley & Hitch, 1974; Grafman, 1989; Norman & Shallice, 1986; Pribram, 
1960). Baddeley and Wilson (1988) went beyond just concentrating on the cognitive 
elements of frontal functions, additionally incorporating the behavioural and emotional 
components. This included behaviours observable by others, such as decision making and 
impulsivity. For instance, the observable aspects of decision making would include 
struggling with complex or conflicting demands. They use the term dysexecutive syndrome 
to understand these observable aspects of frontal dysfunction. It has been argued that the 
use of the word syndrome may be problematic in the conceptualisation of these as there is 
variation in the type of symptoms experienced following a brain injury (Damasio, Tranel & 
Damasio, 1991). For example, some may experience more cognitive impairments, but the 
behavioural and emotional process remain intact, or vice versa (Damasio et al., 1991; 
Stuss, 2007). 
Executive function models 
The term ‘executive function’ was defined by Lezak (1995) as ‘‘those capacities 
that enable a person to engage successfully in independent, purposive, self-serving 
behaviour’’ (p42). Executive function is thought by some to account for the cognitive 
aspects of frontal lobe function. Diamond (2013) distinguishes between ‘core’ and ‘higher-
order’ EF components. Components of ‘core’ EF included working memory, inhibitory 
control, and cognitive flexibility, whereas components of ‘higher-order’ EF are considered 
to be reasoning, problem-solving and planning. Some frameworks considered these 
processes to originate solely within the frontal lobes. However, impairment of EF has been 
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evident in those with injury to differing areas of the brain (Stuss, 2011). Burgess (2004) 
also argued that terms including ‘frontal lobe disorder’ had limitations in not accounting 
for functions linked to other areas of the brain which could co-ordinate these processes.  
The Stuss model 
Stuss’s model (2011) is based on mapping underlying differences in frontal brain 
structures with lesion and imaging research to dissociate specific functions. He identifies 
four different processes: (1) Executive Cognitive functions in dorsolateral prefrontal cortex 
(PFC) regions, (2) Energisation in superior medial areas involved in initiation, (3) 
Behavioural and Emotional Self-Regulation in ventromedial areas and (4) Metacognition 
in anterior medial regions of the PFC which coordinate all the aforementioned processes. 
He also addresses how the connections from the prefrontal cortex to other areas of the 
brain can lead to the similar dysexecutive presentations typically seen in those thought to 
have ‘pure’ frontal brain injuries (Stuss, 2011). 
Measurement of frontal functions 
 Issues with the measurement of frontal functions 
Inconsistency in operationally defining frontal functions makes them difficult to 
measure, with clinicians completing a range of different tasks to tap into the different 
processes thought to underlie these (Cicerone, Levin, Malec, Stuss & Whyte, 2006). 
Clinicians and researchers aim to utilise assessments which can assist with predicting 
problems in day-to-day life, providing diagnosis based on identifying impaired and spared 
functions, and planning and evaluating rehabilitation interventions. Additionally, 
assessment may assist in identifying the mechanisms of frontal or other cognitive processes 
in non-clinical and clinical populations and relating these to underlying brain structures or 
everyday behaviours. Currently, measurement of such difficulties associated with frontal 
functions includes traditional standardised neuropsychological tests, ecological 
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neuropsychological measures and rating scale measures. Due to the task impurity problem 
with the measurement of EF’s, clinicians often rely on completing numerous different 
neuropsychological tasks in order to tap into the range of EF associated difficulties which 
may be faced by individuals (Miyake & Friedman, 2012). This is due to the large amount 
of variance which can influence upon performance in these tasks, which can be attributed 
to non-EF specific factors, such as visual processing (Miyake & Friedman, 2012). 
Additionally, such neuropsychological measures mainly tap into the cognitive processes of 
EF (Chan, Shum, Toulopoulou, & Chen, 2008). Advantages of rating scale measurement 
over these other tools are in their ability to gather a personalised account from the person 
on functional difficulties faced in their everyday life. They therefore may be able to 
capture behavioural, cognitive, social and emotional difficulties making them a potentially 
ecologically valid means for measurement within the constraints of a clinical setting. Their 
measurement has important implications in identifying the most suitable interventions to 
support people with the functional difficulties of which they report. Evidence based 
practice in neurorehabilitation typically involves a mixture of approaches aiming to restore 
functions alongside those aiming to compensate for the impact of deficits in everyday life 
(Turner-Stokes, 2003). Neurorehabilitation additionally aims to improve self-management; 
however, EF difficulties can impair the skills required to self-manage effectively in 
everyday life. Due to the challenge in its measurement and the tendency for those available 
to primarily highlight the ‘core’ cognitive EF’s, dysexecutive problems specific to 
emotional, social and behavioural domains can be missed during assessment (Chan et al., 
2008). This may result in individuals continuing to experience difficulties following their 
rehabilitation (Cicerone et al., 2006). It is also recognised that there can be individual 
differences in non-clinical groups, specifically for EF’s related to updating, shifting and 
inhibition (Miyake & Friedman, 2012). Miyake and Friedman (2012) found that some EF 
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components show unity and diversity, at a latent level show some heritability and that such 
individual differences have some consistency through development. They also found that 
there are links with self-regulatory behaviours and specific EF individual differences. 
Rating scale measurement 
Rating scale measures may offer an ecologically valid means to capture both 
patient and informant views on challenges associated with dysexecutive problems 
(Burgess, Alderman, Evans, Emslie & Wilson, 1998). Further development of these rating 
scale measures may have useful clinical applications in being able to highlight specific 
areas of strength and difficulties which can become a focus for a person’s individual 
rehabilitation plan (Cicerone et al., 2006). Cicerone et al. (2006) detail how rating scales 
can supplement traditional neuropsychological testing to highlight the specific challenges 
to target as part of neurorehabilitation. For example, based on Stuss’s (2011) theoretical 
model, whether problem-solving, prompting, goal management or emotional regulation 
strategies would be most beneficial for a person depending on whether their difficulties are 
due to either activation, awareness, cognitive and/or emotional processes. These can be 
captured within subscales in these rating scales, such as with the development of the 
Dysexecutive Questionnaire Revised (DEX-R) where one study aimed to refine the DEX 
to align it to the Stuss model with an ABI sample (Simblett, Ring & Bateman, 2017). 
Clinical implications and scope of thesis portfolio 
A systematic review of measures would enable clinicians and researchers to 
identify the most psychometrically robust rating scale measures of frontal functions. The 
inconsistency of the conceptual understanding means there is variability in what these 
rating scales claim to measure, for example the tendency to focus on cognitive processes 
and omit social and emotional prefrontal processes in measures such as the Adult 
Executive Functioning Inventory (ADEXI: Thorell & Nyberg, 2008). There has 
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traditionally been a large effort in the measurement of cognitive processes associated with 
EF, however, for clinicians, there may be challenges in finding a measure which also 
includes the social, emotional and behavioural processes known to affect those with frontal 
function impairments. Using additional neuropsychological testing to capture these is 
likely to be time consuming and limited by the constraints of a clinical setting. As part of 
the thesis, a systematic review was carried out focussing on addressing these challenges, 
taking the Lezak (1995, p42) definition of executive function to allow for the inclusion of a 
range of not just cognitive, but also of emotional, social and behavioural processes. What 
constitutes as robust psychometric properties lie in their ability to demonstrate sound 
validity and reliability (Messick, 1989). As well as the review establishing which rating 
scales measuring executive function show the best psychometric properties it will also 
identify whether subconstructs/factors are evident and if these subconstructs map onto 
conceptual models of executive function. Factor analysis and Rasch analysis can be used to 
explore the subconstructs of measures, and to measure construct validity driven by 
theoretical understandings (Boone, 2016; Browne & Cutik, 1993; Brown, 2015; Coffman, 
2014; Wright, 1996). Rasch analysis enables clinicians to understand whether the 
measurement tool they are using is unidimensional or multidimensional. Factor analysis 
groups items into related factors based on responses given. As dysexecutive problems 
encompass behavioural, cognitive and emotional difficulties being able to establish 
subconstructs allows the measurement of the different ways people may be impacted by 
such difficulties (Damasio et al., 1991; Stuss, 2007). In addition, Rasch analysis confirms 
whether the measure is indeed interval, as opposed to making assumptions of what is 
typically classed as an ordinal measure. The review sought to examine whether these rating 
scales apply better for specific clinical or non-clinical groups to support clinicians in 
identifying which may be most appropriate within their setting.  
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The empirical paper will then extend on the systematic review by taking a 
conceptually based rating scale of frontal function to further explore its psychometric 
properties with a non-clinical population. This paper will assess the validity, reliability and 
factor structure of the revised version of the Dysexecutive Questionnaire (DEX-R) and 
whether it is multidimensional in a non-clinical sample and if so whether the factor 
structure maps onto theoretical conceptualisations of frontal lobe functioning. The DEX-R 
has preliminarily been demonstrated to be a valid and reliable measure of dysexecutive 
problems in an ABI and a healthy ageing sample (Dimitriadou, Michaelides, Bateman & 
Constantinidou, 2018; Simblett et al., 2017). The use of a non-clinical sample may 
highlight similar individual differences as found in previous research (Miyake & Friedman, 
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Abstract 
Background: Rating scales are used to measure executive function in addition to 
traditional cognitive assessments in research and clinical practice. A recent review of the 
literature on their psychometric properties has not been conducted. The main objective was 
therefore to review the psychometric properties of rating scales measuring executive 
function. 
Methods: Searches were performed up to April 2020 in EMBASE, PsycINFO, CINAHL 
and MEDLINE. Included papers used an EF rating scale, reporting both a reliability and 
validity statistic. Quality assessment was completed using a modified version of the 
QUADAS-2. Data extraction and a narrative synthesis of the data followed. 
Results: 24 papers were included in the review with 8449 participants. The EF rating 
scales included the DEX, BRIEF, FrSBe/FLOPS, BASC, ADEXI, FBI, ECQ and BDEFS. 
A range of clinical and non-clinical groups were included, and the factor structures varied 
within and between the rating scales. Most had at least adequate validity and reliability. 
The quality of papers was mixed; many did not include an adequate reference standard.  
Conclusions: The DEX, FrSBe and BRIEF-A were the most widely used rating scales 
with adequate to excellent reliability and validity across clinical and non-clinical groups. 
Papers were limited in utilising test-retest reliability and concurrent validity to compare to 
existing EF rating scales. Future research using discriminative analysis could further 
enhance the use of these measures. 
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The term executive function (EF) has been defined as “those capacities that enable 
a person to engage successfully in independent, purposive, self-serving behaviour’’ 
(Lezak, 1995, p42).  EF is “important to just about every aspect of life” (Diamond, 2013, p. 
137) therefore the recognition of such difficulties in clinical settings are important in being 
able to provide relevant interventions. Failure to capture EF difficulties may result in 
individuals continuing to experience problems in their everyday functioning following 
rehabilitation (Cicerone, Levin, Malec, Stuss, & Whyte, 2006). 
 There have been challenges in the measurement of executive function, particularly 
due to constraints on testing within a clinical environment. Clinicians can use performance 
based tests and rating scales to measure EF. Performance based tests include tasks thought 
to tap into certain processes of EF and may be based on a particular cognitive model or aim 
to capture everyday function (or both). Various traditional tasks of EF such as the stroop 
task and the trail making task have had issues in sensitivity to detect frontal deficits despite 
reported or observed difficulties in everyday function (Shallice & Burgess, 1991). 
Therefore, a limitation is the lack of ecological validity by failing to highlight challenges in 
functional difficulties observed or reported by individuals (Holst & Thorell, 2018; 
Manchester, Priestley, & Jackson, 2004; Shallice & Burgess, 1991; Stuss et al., 1983). In 
addition, problem solving abilities require novelty of tasks and so the ability for repeated 
measurement is a shortcoming of these tests (Holst & Thorell, 2018).  
There have been attempts to address these issues of ecological validity of testing in 
a clinical environment by either comparing existing tests to everyday behaviours 
(veridicality) or designing new tests which resemble an everyday task (verisimilitude) 
(Chaytor & Schmitter-Edgecombe, 2003). The Multiple Errands Test and the Six Elements 
Test were designed to provide a less structured assessment to increase demands on EF 
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components, particularly those associated with higher-order EF’s (Diamond, 2013; Malloy 
& Grace, 2005; Shallice & Burgess, 1991). However, there are still some structure and 
implicit prompts present through clinical administration which may not mirror difficulties 
present in everyday life. In addition, these can be time-consuming to administer and may 
not measure all the underlying components (including behavioural, social and emotional 
components) thought to underpin EF (Burgess, Alderman, Evans, Emslie, & Wilson, 1998; 
Chan, Shum, Toulopoulou, & Chen, 2008; Duggan, Garcia-Barrera & Müller, 2018).  
 There is therefore a gap between our conceptual understanding of EF, and the 
cognitive, behavioural, emotional and social difficulties that can be seen in clinical settings 
and experienced in everyday life. To overcome this, rating scale measures have been 
developed to capture reports of these functional challenges which may be experienced 
(Duggan et al., 2018; Isquith Roth, & Gioia, 2013; Toplak, West & Stanovich, 2013). The 
use of self-ratings to measure EF has shown to better capture such processes when 
compared to EF neuropsychological tests (Barkley & Fischer, 2011; Barkley & Murphy, 
2010; Holst & Thorell, 2018; Toplak et al., 2013). However, the poor correlations in 
different types of measurement may be explained by these measuring differing sub-
constructs of EF, or frontal functions (Burgess et al., 1998; McAuley, Chen, Goos, 
Schachar, & Crosbie, 2010; Toplak et al., 2013). Due to these differences in measurement, 
it has been recommended neither method be used standalone and instead self-ratings can 
complement traditional testing well in enhancing overall EF assessment (Toplak et al., 
2013). Furthermore, challenges and different views on operationalising and 
conceptualising EF may explain the inconsistency of EF rating scales and the subconstructs 
and factors they aim to measure (Duggan et al., 2018; Garcia-Barrera, Karr, & Kamphaus, 
2013). A number of different EF scales have been developed and applied across different 
clinical populations and translated into different languages. These are available for children 
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and adults. EF rating scales also offer informant versions further enhancing clinical 
assessments which is of particular use for people who are experiencing reduced self-
awareness of their difficulties. The multiple factors thought to underpin EF has been 
another challenge in its measurement, behaviour rating scales have been developed with 
subscales to capture these different components.  
The psychometric properties of EF rating scales continue to be explored to improve 
their measurement. Reliability is determined by how replicable the measure is (Clark-
Carter, 2009; Messick, 1989). Internal reliability measures the consistency of a measure to 
establish if the questions relate to each other. Test-retest reliability measures whether the 
measure is consistent over time, such as by comparing scores on the measure at two 
different time points which enables the accountability of day-to-day variability. Inter-rater 
reliability compares the degree of agreement in scores between more than one rater (Clark-
Carter, 2009). Those with impairments to EF can have difficulties with self-awareness, and 
therefore the development of measures with sound inter-rater reliability is important. 
Validity refers to whether the measure actually measures what it sets out to, such as the 
construct of EF and its underlying sub-constructs (Messick, 1989). There are different 
types of validity, including concurrent, construct, face, content and criterion validity 
(Clark-Carter, 2009; Messick, 1989). Both reliability and validity are important in 
establishing the psychometric properties of measures as the presence of reliability 
correlates with increased validity of measures (Litwin, 1995). Recommendations on the 
interpretation of such psychometric properties is available in the literature (Hermans, van 
der Pas, & Evenhuis, 2011). Factor analysis and Rasch analysis have been used as a 
measure of construct validity. They provide a basis to understand whether scales are 
measuring multiple components and how specific items group together (Boone, 2016; 
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Brown, 2015; Browne & Cutik, 1993; Coffman, 2014; Wright, 1996). Using subscales can 
allow for the detection of where tailored interventions can be used.  
When identifying which psychometrics are of most importance when reviewing 
rating scales, a number of considerations can be incorporated. In order to understand what 
a useful clinical measure is we need to know whether the content is useful and relevant to 
the patient and the clinician, established by content validity. This also involves the measure 
relating to the neuropsychological construct being assessed via construct validity. In 
addition, when yielding a score, we need to know whether this score is interpretable 
(Fermanian, 2005). In terms of classical test theory, a more reliable measure would 
increase the confidence of knowing where the true score lies. Sound reliability of a 
measure demonstrates internal consistency of the construct being measured and its stability 
over time. When looking at the psychometrics of clinical measures which incorporate 
different domains, factor analysis and item response theory can provide further important 
information to check factor structure and the reliability and validity of subscales (Wu, Tam 
& Jen, 2016).  Furthermore, factor analysis can contribute to determining the conceptual 
nature of a measure. This has clinical advantages in being able to profile strengths and 
difficulties in a particular domain. Concurrent validity involves comparing responses to a 
‘gold standard’ measure to identify whether something meaningful is being measured. It is 
important to be sure EF is being measured in a way comparable to a gold standard. For 
example, identifying the presence of frontal damage or of EF impairments. Therefore, the 
psychometric properties of particular interest in establishing the robustness of a clinical 
measure include content, construct and concurrent validity, and reliability. Important but 
less high priority for a review include how the measure subscales align with 
neuropsychological models, and the extent to which individual items are sensitive to a 
21 
range of abilities.  The stability of such psychometric properties can be guided by whether 
these are evident across diverse samples or contexts on a measure by measure basis.  
Malloy and Grace (2005) completed a review which reported the psychometric 
properties of rating scale measures of frontal functions. This included the Behaviour 
Rating Inventory of Executive Functions (BRIEF; Gioia, Isquith, Guy & Kenworthy, 
2000), the Dysexecutive Questionnaire (DEX; Burgess et al., 1998), the Frontal Systems 
Behaviour Scale (FrSBe; Grace & Malloy, 2001), and the Iowa Rating Scales of 
Personality Change (IRSPC; Barrash, Tranel, & Anderson, 2000). The review also 
included the Frontal Behaviour Inventory (FBI; Kertesz, Davidson, & Fox, 1997) and the 
Neuropsychiatric Inventory (NPI; Cummings et al., 1994). Whilst these were developed to 
capture neuropsychological features of dementia, their inclusion in the review was due to 
their potential to measure deficits associated with frontal functions. The psychometric 
properties of the FrSBe were the most robust, evidencing both reliability and validity 
across different clinical groups. The FrSBe and BRIEF provided comprehensive norms, 
not provided by the other rating scales. The BRIEF also demonstrated reliability, however 
the review reports upon the original child version. Since publication of the review, the 
adult version has become widely available (Roth, Isquith & Gioia, 2005). Only the FrSBe 
and IRSPC evidenced classification between frontal and non-frontal brain injured groups. 
Although, the FBI and NPI were sensitive to behaviour changes such as disinhibition but 
these were largely based on dementia research. The FBI was considered to be highly 
reliable and valid. There was no reliability or norms reported for the DEX, and validity 
was evidenced by a factor analysis. Brain injury groups only differed to control groups 
based on informant versions of the DEX. Research presented in the review considered how 
this may relate to differences in awareness. 
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There has however since been a surge in research in this area as well as on 
operationalising EF and frontal functions. There are several EF rating scales available but 
there has not been a recent review on how these compare to each other in terms of 
psychometric quality. In addition, it is unclear whether different rating scales are more 
suited for particular clinical groups and whether their psychometric quality is stable across 
diverse contexts. Diverse application across clinical and non-clinical populations and 
contexts would allow a greater comparison on how each rating scale performs. For 
example, whether the DEX performs well in differing clinical groups and across different 
countries. If these have been applied broadly, they may highlight whether a rating scale is 
particularly sensitive to EF impairments associated with a specific condition. A lack of 
systematic reviews in this area poses challenges for clinicians and researchers in 
identifying the most robust rating scales to measure specific components of executive 
function. Therefore, the aim of the current systematic review was to focus on the 
psychometric properties across different EF rating scales to address this gap in the 
literature. This will contribute by guiding clinicians in their decision making on selecting 
an EF rating scale based on robustness and/or conceptual structure.    
Review questions: 
1. Which EF rating scale measures are the most robust for clinical application across 
patients with neuropsychological deficits? 
a. Which rating scales measuring executive function show the best psychometric 
properties?  
b. Do these apply better for specific clinical or non-clinical populations? 
c. What subconstructs / factors are evident and do these map onto models of 
executive function?  
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Methodology 
The PRISMA guidelines were used as a guide in completing the systematic review 
(Moher et al., 2009). A protocol for this review was registered with the PROSPERO 
systematic review protocol registry (www.crd.york.ac.uk/prospero/;CRD42019139013). 
Search Strategy: 
Searches of the literature were conducted between 1985 and April 2020 in the 
following four electronic databases: MEDLINE, PsycINFO, EMBASE, and Cumulative 
Index to Nursing and Allied Health Literature (CINAHL). Backward citation searching of 
included papers was conducted, as well as reviewing google scholar for commonly cited 
papers not identified from the main search. Two additional papers were identified in this 
way. The search terms included syntax and Boolean operators adapted for each database 
(i.e. AND, OR). Search terms were grouped to include an executive function term, a scale 
term, a validity term and a reliability term. For executive function, the search terms 
included: "dysexecutive syndrome" OR "exec* func*" OR "dysexec*" OR "Frontal 
Function*" OR "Frontal System*" OR "Exec* Dysfunct*" OR "Executive Impairment*" 
OR "Frontal Lobe Syndrome*" OR “Metacognition” OR “Supervisory Attention” OR 
“Higher Cognition”. For rating scale, the search terms included: "Rat* Scale" OR 
"Summed Rat* Scale*" OR "Psych* Rat* Scale*" OR "Psychiatric Status Rating Scales" 
OR "Questionnaire*" OR "Measurement*" OR "Self-report Measure*" OR "Outcome 
Measure*" OR "Psychomet*". For validity, the search terms included: "Valid*" OR "Test 
Valid*" OR "Statistical Valid*". For reliability, the search terms included: "Reliab*" OR 
"Test Reliab*" OR "Interrater Reliab*" OR "Statistical Reliab*". Limits applied included, 
being published since 1985, being published in English and using human subjects. Only 
those papers published prior to the search date are included in the review.  
Eligibility Criteria:  
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The population under study included participants with a neurological condition or 
illness, neurodevelopmental disorder, or those with a diagnosed mental health condition. 
The review did not limit to specific clinical populations, and those reporting findings from 
research with non-clinical populations were also included. The review focussed solely on 
adult populations.  
Studies were required to fulfil the following criteria: 
 Published since 1985. 
 Used rating scale methods for assessing executive function. 
 Report psychometric properties (both reliability and validity). 
 Published in peer-reviewed journals. 
Studies were however excluded, if: 
 They were not published in English. 
 The measurement was not an EF rating scale. 
 If either only reliability or validity were reported. 
 The sample only included those aged under 18 years of age. 
Data extraction  
Papers were screened and selected by one reviewer (H.W.) based on the above 
eligibility criteria. Duplicate papers were then removed using the software Endnote. Papers 
were screened for eligibility based on the title and abstract. A second reviewer (P.M.) 
examined a randomly selected 20% of these papers. A third reviewer was available for 
adjudicating should this have been required. The full-text versions of these papers were 
then evaluated for inclusion. Relevant data was extracted including: Author and year of 
publication, the number of participants, the population under study, the EF rating scale 
used, the type of rating (self-report or informant), the psychometric properties and their 
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corresponding statistics (reliability, validity and factor structure). Conceptual models were 
commented on where reported. 
Risk of bias (quality) assessment 
Each article was subjected to a quality assessment using a modified version of the 
Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2: Whiting et 
al., 2011) checklist. This assesses four domains: patient selection, index test, reference 
standard, and flow and timing. The authors recommend modifying the quality assessment 
to suit the review question by adding or omitting signalling questions. As the current 
review is not of diagnostic studies the following modifications were made: one signalling 
question was removed from Domain one and Domain three, two were removed from 
Domain two, and an additional signalling question more specific to a psychometric review 
was added to both Domain one and two derived from the original version of the 
QUADAS-2. All four signalling questions for Domain four were retained. The modified 
version of the QUADAS-2 can be found in Appendix D.  
The patient selection was broad to include clinical and non-clinical populations, the 
target condition was EF, the index test was the method by which EF was assessed, and the 
reference standard was the method used to classify the presence of EF. If papers did not 
include a reference standard, then this was rated as not applicable. This was to allow for 
being able to discriminate between papers that had high risk of bias when a reference 
standard was used. 
Analysis 
Narrative synthesis involved integration and comparison of extracted data as follows:  
1. Looking at psychometric properties across all measures  
2. Comparing psychometric properties across participant groups 
3. Comparing factor structure across measures and participant groups 
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The interpretations of psychometric properties were guided by the literature 
(Cheung & Wang, 2017; Hermans et al., 2011). The quality assessment ratings regarding 
the risk of bias and applicability for the four domains of the QUADAS-2 were presented in 
a table. Risk of bias and concerns regarding applicability were rated as either ‘low’, ‘high’, 
‘unclear’, or ‘not applicable’. A graph summarises the proportion of papers with bias 
across signalling questions to allow recommendations to improve quality to be made.  
Results 
Study Selection 
Figure 1 details the process for which the papers were retrieved from the database 
searches. A total of 2512 papers were retrieved, with two additional papers identified from 
manual searches. Following the screening and review stages there were 24 papers included 
in the current systematic review. The study characteristics are detailed in table 1 and 
include author, sample, EF rating scale measure, type of validity and reliability, and for 
those using factor analysis, the number and labels of factors reported. The table also 
presents the quality of the papers included in the review based on the modified version of 
the QUADRAS-2, additionally figure 2 shows the proportion of papers meeting each 
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Not peer-reviewed = 1 
Previous review paper = 1 






























 A total of 8449 participants took part in the studies detailed in the review. Of these, 
2250 were from clinical groups (1183 brain injury, 194 dementia, 741 mental health and 
132 ADHD), 4922 were from non-clinical groups, 253 on healthy ageing, and 1042 
informants. Their ages ranged from 18 – 90 years. The types of ratings included eight self-
report, six were informant based (i.e. family member, carer, staff or researcher), and seven 
including both self and informant ratings. Ten papers explored psychometric properties 
with either solely or including those with an acquired or traumatic brain injury, two with 
neurodegenerative conditions, five mental health, two neurodevelopmental which focused 
on ADHD, and six included non-clinical groups. A number included healthy controls 
which was the case in an additional six papers. Of the non-clinical papers, one focussed 
explicitly on older adults (Dimitriadou, Michaelides, Bateman & Constantinidou, 2018). 
Study Characteristics 
 The majority of papers reported the psychometric properties of already standardised 
EF rating scale measures, with one reporting on the development of a new measure 
(Coolidge & Griego, 1995). There were seven which assessed the DEX or modifications of 
the DEX, five with the BRIEF-A (Roth et al., 2005), four which assessed the FrSBe, two 
for the Barkley Deficits in Executive Functioning Scale (BDEFS: Barkley, 2011) and one 
paper each for the FBI, Frontal Lobe Personality Scale (FLOPs: Grace & Malloy, 1992), 
the Behavioural Assessment System for Children (BASC: Reynolds & Kamphaus, 1992), 
the ADEXI, and the Executive-Complaints Questionnaire (ECQ: Mías, Ruiz, Causse, & 
Verónica, 2017). Most rating scales assessed were the English versions, two included 
translated versions in Spanish (Caracuel et al., 2012; Vélez-Pastrana et al., 2016), one in 
Persian (Mani et al., 2018), one in Italian (Milan et al., 2008), one in Dutch (Beerten-
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Duijkers, Vissers, Rinck, Barkley & Egger, 2019), and one in Japanese (Shinagawa et al., 
2007). All translated versions were also then back translated. 
Only papers which included both a type of validity and reliability statistic were 
included in the review. Type of validity statistic included: Construct Validity (often 
reported as being established by Factor Analysis or Rasch Analysis), Convergent validity, 
Discriminant validity, Content validity, Concurrent validity and Criterion Validity. A 
limited number of papers compared responses to another rating scale measure of EF. The 
reliability statistics included internal consistency, split-half reliability, test-retest reliability 
and interrater reliability. The timeframe for test-retest reliability varied between one week 
and three months. Of those where a factor structure was reported, these ranged from 
between two and five factors as being present in the rating scale.  
Risk of Bias and Quality Assessment 
 All papers were assessed for risk of bias and applicability using a modified version 
of the QUADAS-2. The scores for the domain’s patient selection, index test, reference 
standard, and flow and timing can be found in Appendix E. Figure 2 details aspects which 
consistently may have introduced bias. Only 15 studies included a reference standard, 
those where a reference standard was not a measurement of EF were rated as high, which 
was the case for five studies. No papers scored high across all domains; however, the 
majority of papers were unclear in at least one domain. Typically, the index test was 
appropriate for the review question, however eight papers did not detail the administration 
clear enough to know whether bias may have occurred. Seven papers scored high in patient 
selection due to not using a consecutive or random sample and included either payment or 
were part of a treatment study which may have led to different motivations to take part to 
those who did not. This could bias the measurement of EF as motivation is thought to be an 
underlying component of it (Pessoa, 2009). All but three papers did recruit a sample which 
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was applicable to their review question. The flow and timing domain was often difficult to 
establish due to limited information provided in the papers. The paper by Coolidge and 
Griego (1995) was particularly difficult to interpret due to the limited information in their 
paper. Shinagawa et al. (2007) was the only paper to score low across all domains in both 
bias and applicability. Beerten-Duijkers et al. (2019) and Milan et al. (2008) were both 
particularly strong in their quality, both only would have benefited from a clear description 
of the patient selection. Caracuel et al. (2012) excluded those who were not self-reliant in 
ADL’s, and therefore could have limited applicability due to EF measures being used to 
understand such challenges. 
 
 
Figure 2.  
Proportion of ratings to signalling questions on the QUADAS-2.  
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Selection criteria clearly described?
Consecutive or random sample of participants?
Avoid inappropriate exclusions?
Index text described in sufficient detail?
Ref standard likely to correctly classify the target
condition?
Appropriate interval between index test and ref standard?
All Participants receive a ref standard?
Participants receive the same ref standard?
All participants included in analysis?
Yes No U/C N/A
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Table 1.  
Data Extraction Table 
Author 
(Year) 




Factor Structure Participants (n, 
clinical group) 
 





(Cronbach’s alpha)  
α =.85 
Construct validity: via EFA - - Self-report 4 factors: 
- Initiate and sustain  
- Impulse control and sequencing 
- Excitability 







et al. (2017) 
Internal consistency 
(Cronbach’s alpha)  
ABI α=.89 
Informants α= .89 
 
Test-retest (5 weeks, 
Spearman):  
ABI: r =.88 
Informants: r =.60 
 




2 factors (Self-rating version): 
- Initiating & sustaining actions  
- Impulse control & sequencing 
of heard information 
 
3 factors (Informant version): 
- Initiating, sustaining actions & 
regard for social situations 
- Impulse control & sequencing 
of heard information 







Simblett et al. 
(2012) 
Internal consistency (PSI) 
Multiple analysis: .68 – .81 
Internal construct validity: reported as 






















(n=44, one month, ICC)  
Total: r =.95  
Concurrent validity: FAB vs DEX factors: 
Apathy: r = .45 p<.01  
Planning and monitoring: r = .65 p<.01  
Hyperactivity: r = .31 p<.05 
 
NPI Apathy and DEX Apathy: r = .37 p<.01 
 
- - - - Informant 
report 
3 factors: 
- Apathy  





122 (Caregiver for 





Factor 1: r = .93  
Factor 2: r =.97 
Factor 3: r = .95  
 
Construct validity: via EFA 
        
Papers assessing modifications of the DEX (n=3) 
Shaw et al. 
(2015)  
Internal consistency 
(Cronbach’s alpha)  
Total: α=.85 
Subscales:  
Factor 1: α=.80 
Factor 2: α=.75 







Concurrent Validity (Total score)  
SDS: r = .54, p<.01 
BAI: r = .62, p<.01 
DASS-S: r = .58, p<.01  
GSES: r = -.66, p<0.01 
SWLS: r = -.47, p<.01  
 
Criterion-Related Validity (Discriminant 
Function Analysis): Total Score correctly 
classified 68.6% of cases (λ = 0.90, χ2 [2] = 
102.51, F [2.990] = 54.00, p<.001). 
 
Criterion Validity (Total Score): A one-way 
between-groups ANOVA, statistically 
significant difference among the groups, F(3, 
992) = 36.38, p< .001. 
 
The post-hoc comparisons (Games-Howell 
test) community group reported significantly 
fewer levels of dysexecutive syndrome than 
the depressed and anxious (psychiatric) 
groups. 
 
Construct Validity: via CFA and EFA 
 
- - + +  Self-report 3 factors  
- Inhibition 
- Volition 
- Social Regulation 
 
Mix clinical and 
non-clinical 
 
Total 997  
 




(depressed [n = 
92] and anxious [n 
= 122]),  
 
“Neurologically 
impaired” (n = 
120) 
 
Simblett et al. 
(2017) 
Rasch Analysis  






Internal construct validity: reported as 
examined using Rasch Analysis 



























Self α= .88 
Informant α= .91 
 
Scale ranges: 
Self α= .71-.80 
Informant α= .77-.85 
 
Inter-rater: Non-significant 
differences between self and 
informant  
 
Factorial Validity: via EFA/CFA 
 
Convergent validity: “The significant positive 
correlations between the three symptom 
factors”  
 
Self: r = .65 – .77  








- Motivation and Attention 
- Flexibility, Fluency and 
Working Memory 
- Social Self-Regulation  
Healthy ageing / 
non-clinical 
 
Older adults (n = 
235)  
 
Informants (n = 
187) 
 









Nine clinical scales (α=.69 to 
.91)  
 
Construct validity: EFA and CFA  
 
Convergent validity: (Self-report vs 
informant-report, Pearson’s)  
 
r = .85, p<.01 
 
- - Self-report 
and informant 
report 
EFA 2 factor structure 
- BRI  
- MCI 













BRI α= .93  
MCI α= .95  
GEC α= .97  
 
Test-retest (2 months; n = 30, 
ICC)  
BRI: r = .96 
Convergent validity: 
WCST perseveration r= .03 NS 
EF Composite r= .14 NS 
TMT-B derived r= .02 NS 
RCFT r=.17 NS  
Digit Span backwards r= −.01 NS 
 
Content validity: via EFA 
 
- - +  Self-report 2 factors: 
- BRI  









MCI: r = .93 
GEC: r = .94 
 
























Deaf Group ADHD Index = .83 
Hearing Group ADHD 
Index = .81 
Deaf Group DSM-IV Symptoms Total = .92 
Hearing Group DSM-IV Symptoms Total = 
.93 
 
Correlation to manual (type of correlation not 
reported): 
Deaf ADHD r = .53 p= .07 
Hearing ADHD r = .92, p<.01 
 
+ + + Self-report - Neurodevelopment






















Emotional control α=.84 
Self-monitor α=.70 
Initiate α=.72 
Working memory α=.78 
Plan/organize α=.80 
Task monitor α=.65 
Organization of material α=.78 
 
Test-retest reliability (n= 60, 
one month, Pearson): 
Content validity: The content of the scale was 
confirmed by researchers using the manual 
and EF theory.  
 
Face validity: 5 psychiatrists  
checked the final version (not the 
researchers). 
 
Construct Validity: via Factor analysis 
 
 
- - + +  Self-report CFA – number not reported but 
states confirms the original 







r = .78, p < .001 
 





BRI α= .94 
MCI α= .96 
 






Construct Validity: via CFA and Rasch 
Analysis 








90 TBI and 89 
informants 
 
Papers assessing the FrSBe (n=4) 
Caracuel et 
al. (2012) 




Sample A (ABI) 
Apathy = .70 - .74 
Disinhibition =.73 
Executive dysfunction = .71 - 
.74 
 
Sample B (Relatives): 
Apathy = .87 
Disinhibition = .79 - .83 
Executive dysfunction = .86 
 
Sample C (Control): 
Apathy = 0.71-.72 
Disinhibition = .72 -.73 
Executive dysfunction = .71- 
.75 
 
Construct Validity: reported as examined 
using Rasch Analysis 






- Executive Dysfunction 
Mixed sample 
 




65 TBI / stroke (45 



















Total α= .95  
Apathy α= .88 
Disinhibition α= .84 Executive 
Dysfunction α= .91 
 
Revised model:  
Total α=.93 
Apathy α= .81 
Disinhibition α= .82  
Executive Dysfunction α= .92 
 
Construct Validity: via CFA 
 
 






















Family-T1 = .92 
Family-T2 = .93 
 
Test-retest (7 days, reported 
only as r): 
Self: r = .54 
Family: r = .72 
 
 
Convergent validity with PCRS (only 
reported as r):  
Self-T1: r = -.50  
Self-T2: r = -.53  
Family-T1: r = -.65  
Family-T2: r  = -.71 
 
Construct Validity: via CFA and EFA 
- +  Self-report 
and informant 
report 
CFA: 1 & 3 factor models did not 
fit the data 
EFA: 4 factors (no factor labels) 
(four separate EFA produced 
separate factor loadings each 









moderate TBI and 
63 (62.4%) with 
severe TBI 
 
Velligan et al. 
(2002) 
Internal consistency: 




Executive Dysfunction α=.91  
 
Test-retest: (3 months, 
Pearson’s)  
Total r = .78  
Criterion Validity (Comparison of patients to 
controls):  
Total: F3,177=51.86, p<.0001 Apathy: 
F1,179=156.82, p<.0001; 
Disinhibition: F1,179=16.24, p<.0001; 
Executive Dysfunction: F1,179=58.35, p<.0001  
 
Convergent validity  
(Spearman’s rho) 
 










Apathy r = .68, p<.01 
Disinhibition r = .65, p<.01 
Executive Dysfunction r = .65, 
p<.01 
 
Verbal Fluency: (Apathy r= -.47, p<.01; 
Disinhibition r =.16 NS; Executive function -
r =.43 p<.01) 
 
Trails B Errors: (Apathy r = -.17, NS; 
Disinhibition r =.42 p<.01; Executive 
function r =-.38 p<.01) 
 
Trails B Time: (Apathy r =-.30, p<.01; 
Disinhibition r =.33 p<.01; Executive 
function r =-.48 p<.01) 
 
Continuous performance test 
false alarms (Apathy r =.11 NS; Disinhibition 
r =.22 NS; Executive Function r =-.26 p<.01).  
 
Papers assessing the FLOPS (n=1) 






Split-half = .93 
 
Construct validity:  
Pre-Post comparison by family, not 
significantly correlated for frontal ABI (r = 
.30, p=.16).  
Significant difference in pre-post scores for 
frontal ABI (t = -6.21, p <.001), no 
significant correlation or difference for non-
frontal ABI group (t = -1.69, p = .11).  
 





87 (24 frontal 
ABI, 15 non-
frontal ABI, 48 
healthy controls) 
 
Papers assessing the BDEFS (n=2) 
Beerten-






Self-management to time 
α=.86 
Self-organization α=.92 




Concurrent Validity DEX: r = .92, p<.05 
BIS r =.43 p<.05 
 
92% clinical agreement between English and 
Dutch versions of the BDEFS 
 
- - - Self-report - Non-clinical 
 










Self-management to time 
α=.93 
Self-organisation/ problem 
solving α=.94  
Self-regulation of emotion 
α=.92  
Self-restraint α=.89  
Self-motivation α=.86 
 
Construct Validity via EFA and CFA - + + Self-report 5 factors: 
- Self-Organization/ Problem 
Solving 
- Self-Management to Time 







Papers assessing the FBI (n=1) 






Inter-rater (Cohen k 
coefficient):  
k = .92, p<.0001 
 
Test–retest (2 weeks, Cohen k 
coefficient): k = .90, p<.0001 
Concurrent validity:   
(NPI-P: Frontal items) r = .45; p<0.01  
(FAB) 
r = .31; p< .01 
 
Factorial Validity via EFA 
 
Discriminant validity: 24 FBI 
sub-scores correctly classified 100% fv-FTD, 
90.9% AD and 73.3% with VaD (Wilks k= 
0.0945; F = 4.317; P < .0001). 
 
- - - Informant 
report 
5 factors Neurodegenerative 
72 (dementia; 35 
FTD, 22 AD, 
15 VaD) 
 
Papers assessing the BASC (n=1) 






Problem Solving α=.70 
Attentional Control α=.80 
Behavioural Control α=.66  
Emotional Control α=.70 
 
Convergent Validity (BRIEF-A): 
 
BASC Problem Solving (BRIEF 
Plan/Organize r = .65, p<.01) 
BASC Attentional Control (BRIEF Working 
Memory 
r = .62, p<.01) 
BASC Behavioural Control (BRIEF Inhibit r 
= .49, p<.01) 
 
-  Self-report 4 Factors: 
- Problem Solving 
- Attentional Control 
- Behavioural Control 
- Emotional Control 
Non-clinical 
 



















Full scale α=.91, inhibition 
α=.77, working memory 
α=0.90 
 
Test-retest reliability (2–3 
weeks, bivariate & ICC): r 
=.68 and .72 for bivariate 
correlations and 
between r =.62 and .72 for ICC 
 
Interrater reliability: r = .53 for 
bivariate and r =.49 for the ICC 
 
Convergent validity (ADEXI vs BDEFS r= 
.48-.72, and correlations between ADEXI 
scores and scores from ‘laboratory’ measures 
of EF r <.30) 
 
Discriminant validity, analyses of 
variance (ANOVAs) were used to study 
group difference for the 
ADEXI: classified 85% of the participants in 
the correct category with a sensitivity of 86% 
and a specificity of 84% 
 
Factorial validity via Factor Analysis 
 
- +  Self-report 2 factors: 




202 (adults with 




disorders n = 46, 
and a non‐clinical 
sample  
of university 
students n = 105) 
 
 
Papers assessing the ECQ (n=1) 







Executive Attention α=.84 
Behavioural Flexibility α=.81 
Inhibitory Control α=.58 
 
Construct Validity via EFA and CFA 
 
Convergent Validity: Average Variance 
Extracted: Executive Attention (.49), 
Behavioural Flexibility (.38) and Inhibitory 
Control (.30) 
 
Divergent Validity (p < .001) 
 
-  Self-report 3 factors 
- Executive Attention 
- Behavioural Flexibility 



















Poor planning α=.63 
Task completion α=.66 
Construct Validity: via FA 0 Self-report 3 factors: 
- Decision-making difficulties 
- Poor planning 










Note. Abbreviations: ABI = acquired brain injury, AD = Alzheimer’s dementia, FTD = frontotemporal dementia,  VaD = vascular dementia, EFA = exploratory factor analysis, CFA = confirmatory factor 
analysis, ICC = intraclass correlation coefficient, PSI = Person Separation Index (equivalent to Cronbach’s alpha), NS = not significant, ADEXI  = Adult executive functioning inventory, BASC = Behaviour 
Assessment System for Children, BDEFS = Barkley Deficits in Executive Functioning Scale, DEX = dysexecutive questionnaire, ECQ = Executive Complaints Questionnaire, FAB = Frontal Assessment 
Battery, BRIEF = Behaviour Rating Inventory of Executive Functions, FBI=  Frontal Behaviour Inventory, FrSBe = Frontal Systems Behaviour Scale, GEC = Global Executive Composite (BRIEF), BRI = 
Behavioural Regulation Index (BRIEF), BIS = Barratt Impulsiveness Scale. MCI = Metacognition Index (BRIEF), NPI-P = Neuropsychiatric Inventory, SDS = Self-Rating Depression Scale, BAI = Beck 
Anxiety Inventory, DASS-S = Depression Anxiety Stress Scales, GSES = General Self-Efficacy Scale, SWLS = Satisfaction with Life Scale, WCST = Wisconsin Card Sorting Test, TMT-B = Trail Making 
Test Part B, CAARS-S:L = Conner’s Adult ADHD Rating Scales-Self-Report: Long Version, PCRS = Patient Competency Rating Scale, RCFT = Rey Osterrieth Complex Figure Test, T1 = time one, T2 = time 
two, DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition. *Quality ratings based on the four domains of the QUADAS-2: - donates a ‘low’ rating in a domain; + indicates a ‘high’ 






Synthesis of results  
Psychometric properties across all measures 
The psychometric properties of the DEX were explored in seven papers, these 
included those where adaptations to the original DEX was made. All but two papers used 
the DEX with neurological samples, with one other using a healthy ageing group and the 
other a mixed sample. The DEX displayed good levels of reliability across studies for the 
self and informant versions. The subscales in purely ABI samples also had high internal 
consistency when mapped against the Stuss model of frontal functions. However, it should 
be noted that this was a modified version of the DEX, known as the DEX-R where 
additional items and rewording of the original DEX have been made (Simblett et al., 
2017). The test-retest reliability of the DEX was stronger for self-ratings than for informant 
versions in one paper when these were completed five weeks apart (Hellebrekers et al., 
2017). However, a translated version of the DEX demonstrated high test-retest reliability 
for informant versions in a separate paper completed one month apart (Shinagawa et al., 
2007). The two papers used contrasting aetiology samples, one with an ABI sample and the 
other with an Alzheimer’s dementia sample. Both papers scored relatively equally in their 
quality ratings. The DEX had low to moderate correlations when compared against a 
separate rating scale, and low correlation with the FAB, a neuropsychological test 
(Shinagawa et al., 2007). However, only the apathy domain was compared with the rating 
scale, the NPI apathy subscale, which itself is not an EF rating measure. In addition, the 
NPI apathy subscale has not itself been robustly subjected to validity testing (Cummings et 
al., 1994). Only the planning and monitoring subscale of the DEX had a moderate 
correlation. Moderate correlations were found between the DEX and depression, anxiety 
and self-efficacy rating scales, however these do not form adequate validity testing as they 
are not existing valid EF rating scales to be compared to (Shaw, Oei & Sawang, 2015). 
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Shaw et al. (2015) recognise this limitation recommending concurrent validation against a 
separate EF rating scale be applied in future research. Both shorter and longer versions of 
the DEX had good reliability (Shaw et al., 2015; Simblett et al., 2017). 
 The BRIEF-A was assessed in five papers across different clinical and non-clinical 
groups. The internal consistency was strong for the total and index scores, however, was 
more varied across the nine subscales. This was found in both papers which explored the 
subscale reliability (Ciszewski et al., 2014; Mani et al., 2018). The test-retest reliability 
was high after one month and very high after two months although some methodological 
quality issues were raised in both papers (Mani et al., 2018; Rouel et al., 2016). In terms of 
the validity of the BRIEF-A, the self and informant versions correlated well, but there was 
little or no correlation when compared against neuropsychological tests (Rouel et al., 
2016). Interestingly, when scores were compared again the BRIEF-A manual norms, of 
those with ADHD only those without hearing impairments correlated well (Hauser et al., 
2013). However, this paper had many methodological flaws.  
 The FrSBe was assessed by four papers, this included different clinical and non-
clinical groups. The internal consistency of the subscales varied and was robust for the self 
and informant total scores. In one paper, the clinical and control samples had similar 
internal consistency scores across subscales, but the informant version had increased 
internal consistency scores (Caracuel et al., 2012). However, one of the methodological 
flaws raised with this paper was that all participants were required to be independent in 
activities of daily living, and it is questionable whether this limits the generalisability to 
other ABI groups when assessing EF. Particularly as one of the benefits of such rating 
scales are in identifying functional difficulties which may not be captured by EF tests. 
Test-retest reliability was high for total scores and moderate for the subscales, in addition, 
the total scores correlated well for informant ratings and moderate for self-ratings. These 
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were for retests completed both one week and three months apart. However, one study 
produced test-retest statistics following treatment, which could impact on the consistency 
across time (Velligan et al., 2013). The authors report validity by comparing to a patient 
competency rating scale and neuropsychological tests (Niemeier et al., 2013; Velligan et 
al., 2002). Although the correlations were moderate and high with the PCRS, it is not an 
EF rating scale and therefore does not demonstrate construct validity by comparing to 
another EF rating scale. It is however a measure of self-awareness of deficits which are 
more distinct in EF deficits. Verbal fluency was the only test which had moderate 
correlation with the subscales, but this was just for the apathy and executive function 
subscales (Velligan et al., 2002). The FLOPS had impressive psychometric properties; 
however, this has subsequently been revised and developed into the FrSBe.  
The FBI and ADEXI were both only assessed by one paper each. They had 
excellent internal consistency for total scores. The test-retest and interrater reliability was 
more robust for the FBI. Both had little or no correlation when compared to 
neuropsychological tests (Holst et al., 2017; Milan et al., 2008). The ADEXI had some 
correlation with the BDEFS, the BDEFS was validated against models of ADHD and EF 
(Barkley, 2011). The psychometric properties of the BDEFs were explored by two papers. 
The Spanish version of the BDEFS had good to excellent internal consistency, its factor 
structure mapped well onto the original version, although some items loaded onto differing 
factors to those in the manual (Vélez-Pastrana et al., 2016). A non-clinical sample were 
recruited via convenience sample and the reference standard was an ADHD rating scale, 
whilst this may support its validity based on the Barkley model, a more robust validity 
measure would be comparing it to existing EF rating scales. The Barkley model was based 
on capturing both the “hot” and “cold” EF components. The Dutch version of the BDEFS 
found it correlated well with the DEX, and less so with the BIS-II. The DEX and BDEFS 
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both include subscales viewing EF as multidimensional. Although, the self-regulation 
subscale showed poor correlation with the ‘emotion’ items on the DEX (Beerten-Duijkers 
et al., 2019). The one paper assessing the BASC did use an existing EF measure as their 
reference standard by comparing scores to the BRIEF-A, which yielded low and moderate 
positive correlations (Duggan et al., 2018). The psychometric properties for a shortened 
version of the Coolidge Axis II Inventory were reported in one paper and were less robust, 
with questionable and acceptable internal consistency reported (Coolidge & Griego, 1995). 
The applicability of this paper raised concerns due to only including 17 participants with a 
head injury, despite a large sample size using a non-clinical sample. The psychometric 
properties of the ECQ development and validation focused on Spanish speaking countries 
and was limited to non-clinical groups. Its convergent validity was assessed using average 
variance extracted, which was below the agreement level required across subscales 
(Cheung & Wang, 2017). 
Psychometric properties across participant groups 
ABI samples were explored by eleven papers, seven of which were the sole clinical 
group in the study. Five of these papers examined the original and modified versions of the 
DEX (Bodenburg et al., 2008; Hellebrekers et al., 2017; Shaw et al., 2015; Simblett et al., 
2012; Simblett et al., 2017). Test-retest reliability was greater for self-reports than 
informants on the original DEX, but this type of reliability was only performed by one 
paper (Hellebrekers et al., 2017). Two papers by the same authors addressed issues of 
measurement found within the DEX for ABI samples (Simblett et al., 2012; Simblett et al., 
2017). These aimed to develop a more psychometrically robust revised version, and indeed 
demonstrates internal consistency ranging between adequate and excellent for its revised 
subscales. Its validity was supported by mapping onto a theoretical model of frontal 
functions (Stuss, 2011). The quality could have been improved by providing details of a 
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reference standard. However, all papers assessing the psychometric properties of the DEX 
with ABI samples would have benefited from either using or providing more details of a 
reference standard using an existing EF rating scale to establish external validity. Only 
Shaw et al. (2015) included a validity statistic that went beyond examining construct 
validity by factor or Rasch analysis, however the clinical groups (ABI and mental health) 
were combined together in the analysis. ABI samples were also examined in papers using 
the FrSBe (Caracuel et al., 2012; Carvalho et al., 2013; Niemeier et al., 2013), BRIEF-A 
(Waid-Ebbs et al., 2012), the FLOPS (Grace et al., 1999) and part of a new EF measure 
development (Coolidge & Griego, 1995). However, Coolidge and Griego (1995) only 
included 17 participants as part of their ABI sample finding they scored significantly 
higher than a control sample. Papers using the FrSBe had issues with bias, and one paper 
combined mixed neurological aetiologies. The BRIEF-A had good to excellent reliability, 
however as only one paper was retrieved, there was limited reports of validity statistics 
applied to ABI. Overall, the DEX and its variants appear to be more robust with ABI 
samples. 
Both papers exploring psychometric properties using a neurodegenerative sample 
displayed excellent reliability but were less able to evidence validity (Milan et al., 2008; 
Shinagawa et al., 2007). They showed limited bias and were applicable to similar samples 
and used different EF rating scales, the FBI and the DEX. Milan et al. (2008) reported that 
the FBI was able to correctly classify by type of dementia, with the following being 
correctly classified: 100% fv-FTD, 90.9% AD and 73.3% with VaD (Wilks k= 0.0945; F = 
4.317; P < 0.0001). However, this was based on small sample sizes (35 carers for the FTD 
group) and was not compared against a healthy control group. Additionally, they found 
that the FBI misclassified 26.7% of those from the VaD group into the FTD group. 
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Therefore, this 100% statistic may not be informative, and the results presented here 
should be interpreted with caution.  
The two papers examining the BRIEF-A with eating disorders sample had excellent 
reliability for total scores and the indices, but less so for the nine subscales (Ciszewski et 
al., 2014; Rouel et al., 2016). Limited validity was demonstrated when comparing to 
neuropsychological tests, however self and informant versions correlated well with each 
other. The FrSBe was used with a sample of people diagnosed with schizophrenia, with 
good reliability and validity (Velligan et al., 2002). The DEX also showed excellent 
reliability when used with a sample who had mental health conditions (Shaw et al., 2015). 
Shaw et al. (2015) additionally found that the DEX correctly classified 68.6% of 
participants in a mixed sample, a quarter of these included participants with a mental 
health condition, compared to most of the non-clinical participants being correctly 
classified. They also included neurological samples in this analysis but do not specify the 
proportion correctly classified.  
Two papers which focused on ADHD were retrieved. These assessed the ADEXI 
and the BRIEF-A, both had excellent reliability. However, the responses on the BRIEF-A 
by the ADHD sample only correlated well and significantly with the manual for those 
without hearing impairments compared to those with hearing impairments (Hauser et al., 
2013). Holst et al. (2017) combined an ADHD and mental health sample and the ADEXI 
correctly classified 85% of participants, with sensitivity of 86% and specificity of 84%. 
Six papers assessed the psychometric properties of EF rating scales with non-
clinical populations. The most robust in its reliability was the DEX-R with a healthy 
ageing sample for both the self and informant versions (Dimitriadou et al., 2018). The 
BASC did not correlate well with the BRIEF-A (Duggan et al., 2018). However, in a 
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separate paper the inhibition subscale of the BRIEF-A was the only one to be valid with a 
non-clinical sample (Shaw et al., 2015). Test-retest reliability was only explored by one 
paper, with the BRIEF-A which was highly correlated one month apart (Mani et al., 2018). 
The BDEFS also had excellent internal consistency with a non-clinical sample, but this 
was only explored by one paper (Beerten-Duijkers et al., 2019). Miranda et al. (2019) 
found excellent internal consistency with an Argentinian population, despite not meeting 
criteria for convergent validity the three factors were confirmed via a CFA (Cheung & 
Wang, 2017). 
Factor structure across measures 
 Twenty papers report a factor structure using either factor or Rasch analysis which 
varied across and within the same EF rating scale and participant groups. This included 
eleven using clinical samples, six using non-clinical samples and three applying factor 
analysis with mixed samples. These ranged from between two and five factors. Only the 
two papers using eating disorder samples with the BRIEF-A agreed on their factor 
structure, which was in line with the manuals two indices (Ciszewski et al., 2014; Rouel et 
al., 2016). However, a two-factor model did not fit well when a CFA was then applied 
(Ciszewski et al., 2014). Carvalho et al. (2013) found the original version of the FrSBe to 
be a good fit, however, they produced an alternative model with a slightly improved fit for 
their mixed neurological aetiology sample, using a reduced model where eight of the 
original items were removed. Niemeier et al. (2013) attempted numerous EFA and CFA 
and did not find these fit the proposed subscales of the FrSBe, although they suggest this 
may be due to their smaller restricted sample size only including those with moderate and 
severe TBI. Although five factors were reported in the FBI as accounting for 65% of the 
variance, over 40% was explained by one factor with only three of the items not loading 
onto it (excessive jocularity, incontinence and alien hand) (Milan et al., 2008). Vélez-
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Pastrana et al. (2016) found the Spanish version of the BDEFS had the same factor 
structure as the original English version.  
For the DEX and its modified versions, there was one paper which reports a two-
factor model (Hellebrekers et al., 2017), three which report a three-factor model 
(Dimitriadou et al., 2018; Shaw et al., 2015; Shinagawa et al., 2007) and one paper reports 
a four-factor model (Bodenburg et al., 2008). One paper found different factor structures 
for self-versus informant versions (Hellebrekers et al., 2017). For the BRIEF-A, three 
papers found a two-factor model (Ciszewski et al., 2014; Rouel et al., 2016; Waid-Ebbs et 
al., 2012) and one paper confirmed fit with the original subscales (Mani et al., 2018). The 
FrSBe showed both three factors (Caracuel et al., 2012; Carvalho et al., 2013), and four 
factors (Niemeier et al., 2013). There were five factors in the FBI (Milan et al., 2008), two 
factors for the ADEXI (Holst et al., 2017), four for the BASC (Duggan et al., 2018), three 
factors on the development of a new EF rating scale measure (Coolidge & Griego, 1995) 
and three for the ECQ (Miranda et al., 2019). 
Across clinical and non-clinical groups, the most widely reported factors included 
initiation, apathy or motivation (seven papers), inhibition (eight papers) and self-regulation 
(14 papers). The initiation, apathy or motivation, and self-regulatory factors were 
represented equally across groups, whereas the inhibition factor only appeared in one of 
the six non-clinical papers in comparison to seven of the eleven clinical papers. The three 
papers using mixed clinical samples all found an inhibition factor, these papers all had an 
issue with bias. Although self-regulation was present across studies, in non-clinical papers 
these were reported as discrete emotional, social or behavioural self-regulation factors, 
whereas in clinical papers these were typically combined as a behavioural and emotional 
self-regulation factor. Other factors appearing at least three times across groups were 
executive cognition, decision making and problem solving, and metacognition. Executive 
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cognitive factors were generally equally presented across groups. The metacognition factor 
appeared more so in the papers with clinical groups, and factors relating to decision 
making and problem solving were more present in the non-clinical papers. The DEX and 
its variants captured a broad range of factors, both the BRIEF-A and FrSBe included 
factors in line with their indices/subscales. Other rating scales only included one paper 
where a factor structure was reported.  
Discussion 
Summary of evidence 
 The aim of this systematic review was to evaluate which EF rating measures are the 
most robust for clinical application across patients with neuropsychological deficits. 
Twenty-four studies met inclusion for the final review and included the evaluation of the 
psychometric properties of a range of EF rating scales across different participant groups. 
Many papers focused on ABI samples, additionally, papers included mental health, 
neurodegenerative, and ADHD samples. Additionally, the psychometric properties using 
non-clinical samples were investigated in a number of papers. The rating scales included 
the DEX, BRIEF-A, FrSBe/FLOPS, FBI, BASC, BDEFS, ECQ and the adapted Coolidge 
Axis II Inventory.  
The majority of papers used the DEX (or its modifications), the BRIEF-A, or the 
FrSBe. Overall, these measures had acceptable to excellent reliability and validity for both 
their total and subscale scores. Informant-rating forms appeared to perform better than self-
rated versions, particularly for the DEX and FrSBe. There was greater variation in 
identified subscales and in the psychometric properties across clinical groups, and although 
psychometric analyses were conducted across measures, only three studies assessed 
sensitivity / specificity of classification or identification of clinical conditions, with only 
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one in neurodegenerative conditions and two comparing mental health populations with 
either ADHD or non-clinical groups (Holst et al., 2017; Milan et al., 2008; Shaw et al., 
2015). Internal reliability was the most widely reported type of reliability reported. There 
were promising results for stability and consistency over different time points, but this 
approach was used less frequently. Validity was assessed in different ways, some 
comparing to other EF rating scales, non-EF rating scales and neuropsychological tests. 
This led to issues in an applicable reference standard being used to establish the external 
validity of rating scales, as many would have benefited from comparing to an existing EF 
rating scale measure. Most papers analysed subscale factors, typically finding two to four 
factors in both clinical and non-clinical groups, which commonly covered initiation, apathy 
or motivation, inhibition, or self-regulation in general or broken down into cognitive, 
behavioural and emotional factors. Other factors included metacognition, working 
memory, and decision making or problem solving.  
The variability within the factors thought to underpin the DEX may be due to the 
different attempts to modify the original version (Bodenburg et al., 2008; Dimitriadou et 
al., 2018; Shaw et al., 2015; Simblett et al., 2017). Indeed Shaw et al. (2015) compare the 
original DEX with a revised version incorporating 15 of the 20 items. They completed 
numerous CFA against four existing factor models reported in the literature (Burgess et al., 
1998; Chan, 2001; Mooney et al., 2006; Wilson et al., 1996), finding that these models did 
not fit the data. A revised version of the DEX with modifications to improve fit 
incorporated an additional 14 items with four subscales, following analysis revealing the 
DEX to not be a unidimensional measure (Simblett et al., 2017). However, when the same 
measure was used with a healthy ageing sample, three subscales were revealed 
(Dimitriadou et al., 2018).  
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 Returning to the review conducted by Malloy and Grace (2005), the current 
systematic review supports the robustness of the FrSBe in its reliability and validity across 
different clinical and non-clinical groups. This review expands on the evidence of the 
psychometric properties of the BRIEF, as it includes the adult version which had not be 
devised prior to their review (Roth et al., 2005). The BRIEF-A maintains consistent 
reliability in the total and index scores, however, was less consistent across the nine 
subscales. The FBI was again considered to be highly reliable, however this was based on 
one paper using a dementia sample. Therefore, this review does not extend on its use with 
different clinical groups. The DEX had limited psychometric properties reported in the 
review by Malloy and Grace (2005), the current review significantly expands on this. 
Three papers report on the classification of groups. The FBI was reported to correctly 
classify based on different types of dementia, discriminating with 100% accuracy frontal-
temporal dementia. But this was based on small samples, without a healthy control group 
and misclassified 26.7% of those with vascular dementia into the frontal-temporal 
dementia group. Additionally, the ADEXI was reported to correctly classify 85% of 
participants, with a sensitivity of 86% and a specificity of 84% (Holst & Thorell, 2018). An 
abbreviated version of the DEX was able to correctly classify 68.6% of cases from clinical 
groups (Shaw et al., 2015). However, the clinical groups included neurological and mental 
health samples, and only those in the mental health group scored significantly higher than 
controls. It was not clear whether those in the neurological group experienced frontal 
deficits, and therefore may have been more diverse than those in the mental health group in 
terms of the commonality of cognitive functioning. As found previously, there was again 
limited reporting of the sensitivity and specificity of EF rating scales used with clinical 
groups, and therefore remains a gap requiring further research.  
Strengths and Limitations  
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 Limitations of this review relate to the exclusion of papers based on language and 
the requirement for these to be published in peer reviewed journals. Additional papers may 
have had important contributions towards understanding the psychometric properties of EF 
rating scales, particularly in regard to their application across diverse contexts. The 
overarching goal of the review was to identify which EF rating scales were the most robust 
for clinical application across patients with neuropsychological deficits. This was 
dependent on a range of these measures being applied broadly across these contexts, which 
they were not. One research question related to how EF rating scales compare against each 
other. As each measure was not compared across similar populations and 
countries/contexts this heterogeneity became problematic to synthesis and compare the 
stability of the psychometrics, reducing the robustness of the review findings. A further 
issue with the heterogeneity of EF constructs across studies and rating scale measures 
provided a further barrier to the synthesis of results. This posed a challenge in interpreting 
how these apply to EF theory, as each measure should capture the different constructs of 
EF so that they can distinguish between clinical groups with their differing profiles of 
strengths and difficulties. Comparing less diverse samples across papers would allow for 
enhanced understanding of the psychometric quality of rating scales but would be limited 
in how generalisable these would be in different clinical contexts and conditions. 
Therefore, this review was not able to easily conclude on the most robust measures due to 
these limitations with heterogeneity. Robust psychometric statistics required both validity 
and reliability to be assessed by papers, additional papers reporting on either reliability, 
validity or factor structure are likely to be more widely available and may have 
strengthened the ability to understand how these apply to different clinical groups. 
Furthermore, this requirement limited the retrieval of papers which may have exclusively 
focussed on the content, concurrent or construct validity of individual rating scales. These 
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validity statistics were outlined as being useful determinants of their psychometric quality. 
A strength of the review is the consistent approach taken in the interpretation of reported 
statistics based on a previous systematic review (Hermans et al., 2011). There currently is 
not a quality check available explicitly for use with psychometric studies. The QUADAS-2 
is available for diagnostic studies and the authors recommend modifying it to suit specific 
review questions. It has previously been applied to systematic reviews of psychometric 
studies. Due to the constraints of the thesis, there was no reviewer for the final full-text 
review and quality checks which were only completed by one researcher which could lead 
to bias. However, the high level of agreement found between reviewers during the 
screening phase provides a degree of confidence (Appendix F). The challenges in 
conceptualising EF meant broader search terms were included.  
In terms of the key limitations of the reviewed studies, one challenge was the lack 
of a reference standard in many of the papers, which usually is available in diagnosable 
conditions. However, EF already has issues in conceptualisation and measurement, and 
therefore it is difficult to ascertain what the best reference standard would be. There was no 
universal reference standard used, varied approaches were taken such as brain imaging, 
clinical interviews, EF rating scales and neuropsychological tests. Some papers used non-
EF rating scales which have limited applicability when establishing whether the index test 
is a valid measure of EF. Shaw et al. (2015) recommend further research with the DEX 
assesses its concurrent validity by comparing to another EF rating scale measure. There 
were varied correlations against neuropsychological tests, however this again could be due 
to differing components of EF being measured. One study showed strong correlation 
between a verbal fluency task and the apathy subscale of the FrSBe (Velligan et al., 2002). 
This is in keeping with the Stuss model in which poor verbal fluency performance may be 
observed in those reporting poor energisation abilities. Therefore, EF rating measures need 
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to be more specific in relating tests to specific questionnaire domains. The factors reported 
in the papers reflect the ‘higher-order’ EF’s more so than ‘core’ EF processes commonly 
measured by neuropsychological tests. This supports the use of rating scale measures being 
used alongside neuropsychological tests to enhance assessment, as opposed to one 
replacing the other. The recognition of different methods capturing different processes was 
what initially led to the development of the DEX (Burgess et al., 1998). Furthermore, a 
huge challenge in the ability to report on the quality of papers with the limited information 
provided by some of the authors. This meant it could not be determined whether they had 
met the specified criteria, whilst other papers were more transparent in their reporting of 
the methodological process and limitations of these. Therefore, this represents a confound 
in the reporting of quality within the current review. Papers using neurodegenerative 
samples were rated as being at the lowest risk of bias and most applicable, whereas papers 
using ADHD, mental health or mixed samples had a high level of bias in at least one 
domain. The DEX and BRIEF-A studies had lower risks of bias in all but one paper each, 
whilst papers using the FrSBe scored high in at least one domain. Returning to the extent 
that measures looked at content, concurrent, construct validity and reliability as outlined in 
the introduction, different approaches were used to achieve this. Reports of the content 
validity of rating scales were limited. Where construct validity was reported this was often 
via a factor analysis. Concurrent validity was reported in some of the papers by comparing 
to an EF rating scale which has already been validated. However, it was difficult to 
ascertain what would be a ‘gold standard’ measure to compare to. Many papers assessed 
validity through discriminative or convergent validity which have the added value of 
comparing to neuropsychological tests or looking at the sensitivity and specificity of 
measures. Whilst these validity types were not reported as being of most importance, they 
may be useful for clinicians in determining how a particular rating scale overlaps with such 
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tests or how well they would identify an EF impairment. All papers were required to report 
at least one reliability statistic which mostly included internal consistency with some 
additionally reporting test-retest reliability. The secondary purpose of utilising factor 
analysis or item response theory was applied in a number of papers.  
Implications for future research 
The review of specific measures was limited due to the restricted application of 
these measures across different clinical groups and contexts. The review by clinical group 
was again limited due to insufficient numbers of studies using one measure across different 
groups or multiple measures across matched groups. This led to the issue with 
heterogeneity and could be addressed in two ways. Firstly, by conducting further research 
using more systematic data collection applying each measure across different clinical 
groups and contexts. Secondly, by a comparison of different measures with single clinical 
or non-clinical groups. If this research had been done, then this would have allowed us to 
systematically compare and contrast between different measures for the same clinical 
group, as well as examining the performance of a specific measure across multiple contexts 
and populations. Furthermore, it would enhance our understanding of the EF constructs 
reported and how these vary across rating scale measures and clinical groups. 
Conclusions 
 To conclude, the psychometric properties of a range of EF rating scale measures 
have been studied. The DEX, BRIEF-A and FrSBe were the most widely used across 
clinical and non-clinical groups with robust reliability and validity statistics reported. 
Papers would have benefited from assessing concurrent validity by comparing against 
existing EF rating scales. Additionally, further evidence to demonstrate their consistency 
over time would improve robustness. The challenges of the conceptualisation of EF and its 
underlying sub-constructs has perhaps led to there being no universally agreed factor 
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structure present across measures. Interestingly, non-clinical groups also show multiple 
underlying factors. Attempts have been made to adapt existing measures, such as the DEX, 
to measure conceptual theoretical frameworks such as those proposed by Stuss. Further 
research in the development of a quality assessment suited to psychometric studies would 
be beneficial for future reviews of this nature.  
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The systematic review established a range of valid and reliable rating scales used in 
the measurement of executive function. These could provide an ecologically valid 
alternative or supplement to traditional neuropsychological testing. The most widely used 
measure was the DEX including those where modifications to the DEX were made. Most 
of the reviewed papers assessed psychometric properties of EF rating scales using different 
clinical groups. Papers also used non-clinical populations to assess psychometric properties 
with individual variations being found. The review highlighted inconsistency in the 
underlying subconstructs in the measurement of EF, and differences in the rating measures 
subscales to reflect this. The Stuss model fractionates frontal functions into four distinct 
components. This has benefits over unitary models to capture the wide-ranging difficulties 
that can be experienced. 
The Dysexecutive Questionnaire (DEX: Burgess, Alderman, Evans, Emslie & 
Wilson, 1998) was subjected to modifications based on psychometric investigations to 
produce a conceptually sound measure of dysexecutive problems (Simblett & Bateman, 
2011; Simblett et al., 2017). This revised version of the DEX includes subscales mirroring 
the Stuss model. Two papers were retrieved in the review assessing the DEX-R, 
demonstrating it to be a valid and reliable measure with a brain-injured and healthy ageing 
population (Dimitriadou, Michaelides, Bateman, & Constantinidou, 2018; Simblett et al., 
2017). Papers assessing the DEX-R would have benefited from the use of a reference 
standard to further improve quality. Indeed, this was a recommendation by Shaw, Oei and 
Sawang (2015) who suggested future research on the DEX should assess concurrent 
validation by comparing to another validated EF rating scale. Also, test-retest reliability 
may further enhance the psychometric properties of the DEX-R.  
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What is known so far about the DEX-R is based on clinical populations. This 
provides useful information for clinicians working with these client groups however tells 
us less about how it is applied to non-clinical populations. There is known individual 
variation of dysexecutive problems in non-clinical samples (Chan, 2001; Miyake & 
Friedman, 2012). Any construct is going to vary in the population and share some overlap 
with clinical groups. Whether certain items on the DEX-R are more likely to be endorsed 
by clinical or non-clinical groups is not yet known. Understanding the extent that these 
behaviours are present in a non-clinical population would support clinicians to determine 
what scores are significantly unlikely and could indicate a clinical impairment. Further 
analysis with non-clinical populations may assist in understanding the impact of individual 
differences which may contribute to variability in the factor structure of dysexecutive 
problems. A key clinical challenge is whether a person being assessed may have had some 
of the behavioural characteristics associated with these difficulties prior to their injury. 
Therefore, understanding the most commonly reported characteristics in the general 
population could contribute to what is classed as clinical. This could support clinicians and 
researchers to understand what is being measured in addition to any frontal deficits.  
The empirical paper will therefore assess the measurement properties of the DEX-R 
further with a non-clinical population by assessing its test-retest and internal reliability, 
and validity. Further exploration of the factor structure of the DEX-R will be conducted 
using factor analysis and Rasch analysis to investigate whether the sub-constructs on which 
it was based with the Stuss model continue to be found in a non-clinical population. 
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Abstract 
Aims: The aim of this study was to assess the psychometric properties of the revised 
version of the Dysexecutive Questionnaire (DEX-R) with a non-clinical sample.  
Methods: The study was hosted online, with 140 participants completing the DEX-R, 
GAD-2 and PHQ-2. A proportion also completed the FrSBe, with some additionally 
completing the DEX-R again three weeks later. Correlations of demographic factors and 
symptoms of anxiety and depression were conducted. Rasch and factor analysis were also 
used to explore underlying subconstructs. 
Results: The measures did not display normal distributions, and so transformations and 
non-parametric statistics were applied. The DEX-R correlated highly with the FrSBe, 
indicating sound concurrent validity. Internal consistency, split-half reliability and test-
retest reliability were excellent. Age and symptoms of depression and anxiety correlated 
with DEX-R scores, with older age associated with less dysexecutive problems. The Rasch 
analysis confirmed the multidimensionality of the rating scale, and a three-factor structure 
was found relating to activation-self-regulatory, cognitive and social-emotional processes. 
Frequencies of responses on DEX-R items varied, many were not fully endorsed. 
Conclusion: Interpretations of dysexecutive problems should also consider mood and 
individual variation. Comparison to clinical groups could identify what constitutes as 
clinical levels of dysexecutive symptoms. 
 




 According to the charity Headway, there were an estimated 348,453 hospital 
admissions due to acquired brain injury (ABI) in 2016 - 2017 in the United Kingdom 
(Headway, 2018). An ABI is an acute injury to the brain that happens after birth. It is 
‘acquired’ in the essence that the person did not have this neurological injury prior to the 
event. It, therefore, does not include those of a progressive nature nor those which have a 
genetic predisposition. The damage can be classified as either focal (localised) or non-focal 
(diffuse) and includes both traumatic and non-traumatic brain injuries (Teasell, 2007; 
Turner-Stokes, 2003). Turner-Stokes (2003) explains how ABI can arise through “trauma, 
vascular accident (e.g. stroke), cerebral anoxia, other toxic or metabolic insult (e.g. 
hypoglycemia), infection (e.g. encephalitis) or other inflammation (e.g. vasculitis)” (p14). 
These conditions can result in physical, cognitive, communication and emotional 
difficulties (Wilson, Gracey, Evans & Bateman, 2009). Those who have sustained a 
traumatic brain injury often present with difficulties associated with frontal lobe function 
(McDonald, Flashman, & Saykin, 2002), this is due to the size, structure and location 
making the frontal lobes particularly vulnerable following road traffic accidents and 
assaults (Cicerone, Levin, Malec, Stuss, & Whyte, 2006; Levin, et al., 1987). Research on 
the structure and function of the frontal areas of the brain highlights several roles in 
cognitive, behavioural and emotional processes. These include flexible thinking, planning, 
monitoring, social behaviour, decision making, initiation, inhibition and emotional 
regulation (Lezak, 1995). The term dysexecutive problems has been used to describe 
difficulties with these functions, which can have a profound impact on a person’s level of 
independence resulting in challenges in day-to-day life (Hanks, Rapport, Millis, & 
Deshpande, 1999). They are thought to affect around 40% of people who have a stroke 
(Hoffmann & Schmitt, 2006; Pohjasvaara et al., 2002). 
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 Different theoretical models have been proposed to account for the kinds of 
problems observed in people with acquired damage to the frontal lobes. Early models best 
understood these as being a unitary process (Baddeley & Hitch, 1974; Grafman, 1989; 
Norman & Shallice, 1986; Pribram, 1960). However, evidence from the clinical and 
research literature began to consider how various frontal functions were, in fact, 
dissociable due to differences in presenting functional difficulties reported by individuals 
(Damasio, Tranel & Damasio, 1991; Stuss, 2007). Also, the focus on such processes being 
executed solely in the frontal lobes shifted to the recognition of the involvement of wider 
neural networks and circuits (Burgess, 2004; Fuster, 2008; Stuss, 2011). Despite these 
shifts in understanding, there continue to be discrepancies in operationally defining these 
processes. Although, most models recognise some overlaps being present in their unity and 
diversity (Miyake & Friedman, 2012).  
 There have also been challenges in the measurement of dysexecutive problems, 
with various different approaches to their assessment. Neuropsychological tests can be 
time-consuming requiring complex interpretations. Additionally, they have been criticised 
for lacking ecological validity due to testing in a well-structured environment with cues 
being provided (Burgess, Alderman, Evans, Emslie & Wilson, 1997; Damasio et al., 1991; 
Eslinger & Damasio, 1985). As a result, these tests often fail to highlight difficulties in this 
area despite reports of challenges in day-to-day life (Shallice & Burgess, 1991; Stuss & 
Benson, 1983). To overcome this, self-report measures have been developed to capture 
challenges faced in everyday life. A limitation of using these with people with 
dysexecutive problems is the issue of reduced self-awareness, meaning they may be more 
likely to underreport such difficulties (Simblett, Ring & Bateman, 2017). Informant 
versions are available for those close to the person to be able to corroborate or assess the 
discrepancy compared to the self-report version. Different rating scales have been 
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developed and are available for clinical use, however, there are issues in the 
standardisation and interpretation of scores. This is because the nature of these difficulties, 
such as decision making, perseveration and flexibility, could lead to issues with the 
reliability of item responses.   
The Dysexecutive Questionnaire (DEX; Burgess et al., 1998) forms part of the 
Behavioural Assessment of the Dysexecutive Syndrome (BADS: Wilson, Alderman, 
Burgess, Emslie & Evans, 1996). The DEX is a self-report measure of dysexecutive 
problems, designed to predict everyday difficulties. There are 20 items measuring 
behavioural, cognitive, motivational and emotional changes from pre-morbid functioning 
generating in a single score.  
Simblett and Bateman (2011) assessed the psychometric properties of the DEX 
using item response theory by deploying Rasch analysis techniques. Their analysis 
suggested the DEX not to be a unidimensional measure of dysexecutive problems, instead 
capturing underlying sub-constructs thought to underpin these difficulties. Therefore, a 
total score on self-report measures may not best capture these challenges. In further 
research, Simblett et al. (2017) made amendments to the wording of some of the items in 
the DEX as well as including an additional 14 items to expand its measurement to 
incorporate Stuss (2011) proposed categories of dysexecutive problems. After applying 
Rasch techniques, data from a clinical sample suggested the revised version of the DEX 
mapped onto the Stuss model capturing four separate sub-constructs of executive cognitive 
functions, metacognition, activation and, behavioural and emotional self-regulation. Such 
development has useful clinical applications to highlight specific areas of strength and 
difficulties which can assist in diagnosis, neuropsychological formulation or become a 
focus for a person’s individual rehabilitation plan. For example, based on Stuss’s (2011) 
theoretical model, whether goal management or emotional regulation strategies would be 
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most beneficial. The DEX-R has some additional evidence of psychometric quality when 
applied to healthy ageing and mental health samples (Dimitriadou et al., 2018; Loschiavo-
Alvares et al., 2013). Although neither factor analysis with these groups yielded factors 
that aligned with Stuss’s model.  
Neurological disorders are known to contribute to reports of dysexecutive 
problems, however, additional understandings of how individual variation may manifest is 
useful for clinicians to understand. Research has highlighted individual variations in 
reported levels of dysexecutive problems in non-clinical populations as measured by the 
DEX questionnaire (Chan, 2001). One variable relates to age. Normal ageing processes 
have been associated with a decline in various cognitive functions associated with 
prefrontal areas (Van Petten et al., 2004; West, 1996). This may be more prominent in 
cognitive changes related to the dorsolateral regions, with less change from normal ageing 
being found in ventromedial areas thought to underpin the emotional processing aspects of 
dysexecutive problems (MacPherson, Phillips, & Della Sala, 2002). The relationship 
between normal ageing and dysexecutive problems may have implications in the 
management of activities of daily living. Literature also suggests the prefrontal regions of 
the brain mature later than more posterior areas, with development continuing throughout 
adolescence and towards a person’s early 30’s (Barkley, 2012; Coffman, 2014). The role of 
the ventromedial prefrontal cortex (VMPFC) has been particularly implicated in social and 
emotional processing (Burnett, Bird, Moll, Frith & Blakemore, 2009; Pfeifer et al., 2011; 
Sebastian et al., 2011). This could have implications in the social and emotional functions 
associated with the VMPFC being less developed in younger people. Negative affect has 
been found to mediate the increased reports of dysexecutive problems in younger people 
(Gerstorf, Siedlecki, Tucker-Drob, & Salthouse, 2008). Correlations have been found 
between dysexecutive and anxiety and depression symptoms, which may relate to 
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cognitive variability in mood (Shaw, Oei & Sawang, 2015). In addition, it has been 
proposed that the development of working memory abilities arise later than processes 
relating to set-shifting/cognitive flexibility between adolescence and young adulthood 
(Huizinga, Dolan, & van der Molen, 2006). Another factor contributing to variation in 
reports of dysexecutive problems includes education level (Faria, Alves, & Charchat-
Fichman, 2015; Foss et al., 2013).  
There is currently a gap in the literature relating to the psychometric properties of 
the DEX-R with a non-clinical population. It would be useful to establish variations within 
the DEX-R, due to reports of dysexecutive problems in non-clinical populations with 
potential individual differences contributing. Additional benefits in collating this data 
would be used in normative data to allow comparison in how an individual may be 
expected to perform at a given age if they had no prior condition or injury. 
Research Questions 
The proposed study aimed to assess the psychometric properties of the DEX-R 
further. The primary research questions were: 
1. What are the measurement properties of the DEX-R within a non-clinical 
population? 
1a. Is the DEX-R a reliable measure of dysexecutive problems? 
1b. Is the DEX-R a valid measure of dysexecutive problems when compared to an 
existing valid self-report measure? 
2. Does the DEX-R perform as an interval level measure as established by item 
response theory? 
3. What is the factor structure of the DEX-R in a non-clinical population? 
3a. Does the factor structure align with the Stuss model? 
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 In addition, there were secondary research questions: 
4. What are the effects of demographic and mood variables on DEX-R and DEX-R 
subscale performance? 
4a. What are the effects of age on DEX-R and DEX-R subscale performance? 
Method 
Design 
Quantitative methods were used to test the research questions utilising a within-
subjects cross-sectional design. Participants took part in all aspects of the study by 
completing all questionnaire measures as well as the option to complete the test-retest 
phase at a second timepoint.  
Participants 
The study aimed to capture a broad sample of the population; participants were 
only required to be aged 18 years of age or over. As the study investigated whether there 
are changes based on age, there was no upper age limit. Questions relating to health were 
included as part of the study to allow for monitoring whether clinical factors explained 
variance in the data, should this have arisen. Participants were recruited into the study 
online via a snowball sampling recruitment method whereby information about the study 
was distributed online through the research team’s networks, including social media. 
Separate sample size estimates were calculated for each question, the largest requirement 
being for correlation analyses, requiring at least 109 participants. This was calculated using 
G* Power 3.1.9 (Faul & Erdfelder, 1992), with power set at 0.9 to detect a medium effect 
size and probability was set at .05. This calculation was repeated for the multiple 
regression analysis with the addition of there being four variables included in the model, 
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which indicated 82 participants were required for this analysis. The literature was 
consulted for the required sample size for other analyses.  
Measures 
Dysexecutive Questionnaire-Revised 
The DEX-R is a 37-item questionnaire measuring dysexecutive problems which 
were developed following research conducted by Simblett and Bateman (2011) on the 
DEX Questionnaire (Burgess et al., 1998). A Rasch analysis found the DEX Questionnaire 
to not be a unidimensional measure of dysexecutive problems, suggesting it measures more 
than one construct. An additional 14 items were included and rewording of the DEX was 
made to improve fit to the Stuss model, resulting in the DEX-R. The psychometric 
properties of the DEX-R have been explored with a clinical sample (Simblett et al., 2017). 
This showed good internal reliability. The measurement of underlying sub-constructs of 
dysexecutive problems appeared to map well onto the Stuss model, namely, activation 
regulatory functions, behavioural-emotional self-regulatory functions, metacognitive 
functions and executive cognitive functions. These four terms are also used to name the 
differing subscales within the DEX-R. It is measured using a Likert scale, with response 
options within the DEX-R including: “Very often”, “Fairly often”, “Sometimes”, 
“Occasionally”, and “Never”. These responses are coded as 0 (never) to 4 (very often), 
with higher scores indicating greater reports of dysexecutive problems.  
Frontal Systems Behaviour Scale (FrSBe) 
The FrSBe is an already validated measure of the self-report of dysexecutive 
problems which has been normed against non-clinical samples, responses therefore formed 
part of the concurrent validity testing phase (Grace & Malloy, 2001). Other measures were 
considered however these were either not as well validated or the subscales did not align as 
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well with the DEX-R. Responses are coded as 1 (almost never) to 5 (almost always), 
however, reverse scoring is applied to a selection of items. Higher scores indicate more 
reported dysexecutive problems.  
The FrSBe includes 46-items generating a total score or split across three sub-
systems: executive dysfunction, apathy and disinhibition. It is for use with those aged 
between 18 – 95 years old. It takes approximately 10 minutes to administer and 15 minutes 
for scoring. Research has demonstrated high internal consistency for total score and 
subscale scores ranging from 0.78 – 0.94 in neurological, mental health, non-clinical 
samples (Grace & Malloy, 2001; Stout, Ready & Grace, 2003; Velligan, Ritch, Sui, 
DiCocco & Huntzinger, 2002). Construct validity and factor analysis supports the three 
factors of apathy, executive function and disinhibition thought to underpin the measure in 
various samples (Carvalho, Ready, Malloy, & Grace, 2013; Grace, Stout, Malloy, 1999; 
Stout et al., 2003). Coefficients are reported from a normative sample, 0.92 for the total 
score, 0.78 for apathy, 0.80 for disinhibition and 0.87 for executive subscales (Malloy & 
Grace, 2005).  
The Generalized Anxiety Disorder Scale 
The Generalized Anxiety Disorder scale (GAD-2) is a short, self-report measure of 
anxiety with a sensitivity of 65% and specificity of 88% for any anxiety disorder 
(Skapinakis, 2007). It asks participants how often in the past two weeks have two criteria 
occurred: “Feeling nervous, anxious or on edge” and “Not being able to stop or control 
worrying”. It is measured using a Likert scale, with response options “Not at all”, “Several 
days”, “More than half the days” and “Nearly every day”. These are coded as 0 (not at all) 
to 3 (nearly every day). Higher scores suggest an increased presence of anxiety symptoms, 
with a clinical cut-off equal to or above three points (Skapinakis, 2007). 
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The Patient Health Questionnaire 
The Patient Health Questionnaire (PHQ-2) is a short, self-report measure with a 
sensitivity of 79% and specificity of 86% for detecting symptoms of depression (Löwe, 
Kroenke & Gräfe, 2005). The PHQ-2 is formed of two questions asking how often 
individuals have experienced the following in the past two weeks: “Little interest or 
pleasure in doing things” and “Feeling down, depressed and hopeless”. It is also measured 
using a Likert scale, with response options “Not at all”, “Several days”, “More than half 
the days” and “Nearly every day”. These are coded as 0 (not at all) to 3 (nearly every day). 
Higher scores suggest an increased presence of depressive symptoms with a clinical cut-off 
with a score of three or above (Löwe et al., 2005). 
Demographic Questions 
Demographic questions included questions on age, gender, highest education level, 
years of education and ethnicity.  
Health Questions 
Additional questions regarding health included: “Have you ever been formally 
diagnosed or hospitalised for the following conditions?”, and included neurodegenerative 
conditions (e.g. dementia, Parkinson’s disease, Huntington’s disease, Multiple sclerosis), 
neurodevelopmental conditions (e.g. autism spectrum disorder, attention deficit disorder 
(ADHD), learning disability), acquired brain injury, stroke, and mental health conditions 
(e.g. Bipolar disorder, Schizophrenia or Psychotic Illness). An “other” or “prefer not to 
answer” option was also available. These were included to monitor whether clinical factors 
explained variance in the data.  
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Procedure 
The study was made available online via Qualtrics survey software (Snow & Mann, 
2013). It was circulated online by the research team’s network. Participants were first 
directed to the participant information sheet and could opt-in by providing an email 
address. A link to the study with a password for access was sent, this enabled access to a 
consent form. Participants were then directed to the DEX-R questionnaire, the FrSBe, 
PHQ-2, GAD-2, demographic questions and questions regarding their health. Participant 
were assigned with an ID number and they could opt in to be sent another link three weeks 
later to complete the DEX-R for a second time as part of the test-retest phase.  
Ethical Considerations 
The study was approved by the Faculty of Medicine and Health Sciences Research 
Ethics Committee at the University of East Anglia (UEA), reference number 201819 – 032 
(Appendix G). Participants gave informed consent and they were made aware of their right 
to withdraw by closing the survey. 
Analysis 
Data cleaning was completed to ensure responses in the spreadsheet were in 
accordance with instructions for the questionnaire, such as the removal of incomplete 
datasets. Parametric assumptions were checked using histograms and Shapiro-Wilk tests. 
Where item responses were not normally distributed transformations were attempted, 
otherwise non-parametric alternatives were used. Homogeneity of variance was checked 
using Levene’s test of equality of variance for t-tests. The study used these techniques as 
the removal of outliers would limit interpretations of non-clinical responses on the DEX-R, 
which could make comparisons with clinical groups difficult. If limited data relating to 
clinical factors were retrieved to provide analysis on variance, then these responses were 
removed from the analysis. These were retained for future analysis due to consent being 
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gained for these purposes. To provide consistency in reporting, interpretations of 
psychometric properties were derived from the literature (Hermans, van der Pas & 
Evenhuis, 2011). 
Data were analysed using the Statistical Package for the Social Sciences (SPSS), R, 
and RUMM 2020/2030.  
1. What are the measurement properties of the DEX-R within a non-clinical 
population? 
Measurement properties of the DEX-R were explored by assessing its reliability 
and validity. Internal reliability of the DEX-R was assessed using Cronbach's standardised 
α and split-half reliability which measure the consistency of the questionnaire to establish 
whether the questions relate to each other (Cronbach, 1951; Messick, 1989). A criticism of 
these are their lack of accountability for day-to-day variability. Therefore, test-retest 
reliability was also assessed using Intra Class Correlation (ICC) to measure whether the 
questionnaire is consistent over time. A three-week interval for the test-retest phase was 
chosen in line with previous research (Cummings et al., 1994; Gioia, Isquith, Guy & 
Kenworthy, 2000; Holst & Thorell, 2018). A score of 0.7 or above is recommended to 
establish adequate reliability (Hermans et al., 2011).  
Validity refers to whether the questionnaire actually measures what it sets out to, in 
this instance, whether the DEX-R measures dysexecutive problems (Messick, 1989). This 
was assessed through concurrent validation, by establishing if there was any correlation 
between the DEX-R and another validated measure of dysexecutive problems, the FrSBe. 
This was completed using Pearson Product Moment Correlation Coefficient. 
2. Does the DEX-R perform as an interval level measure as established by item 
response theory?  
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 Rasch analysis was completed using the software RUMM2030 (Andrich, Sheridan 
& Luo, 2009). It is underpinned by item response theory which aims to calibrate both the 
difficulty of items as well as an individual’s ability. It establishes whether a questionnaire 
can be classed as an interval level measurement, as opposed to ordinal. Whether the DEX-
R performs as a unidimensional measure was also explored with Rasch analysis because 
this identifies whether it is formed of subscales. If the chi-square value is not significant 
this confirms there is a misfit with the Rasch model, and therefore infers it is a 
unidimensional measure. If the data does differ significantly, this implies that the DEX-R 
is not a unidimensional measure, and therefore measuring multiple subconstructs. 
Multidimensionality was explored further by the factor analysis detailed below.  
3. What is the factor structure of the DEX-R in a non-clinical population? 
Exploratory factor analysis (EFA) was used to establish whether the underlying 
structure and latent constructs match onto the Stuss model and whether this supports 
previous research with the DEX-R with a clinical population (Simblett et al., 2017). The 
decision on the number of factors to extract was determined by a parallel analysis using R 
software (Horn, 1965). It is recommended that an oblique rotation is first applied, and if 
the factor correlations are above .32 then this rotation is maintained (Pedhazur & 
Schmelkin, 1991; Tabachnick, Fidell & Ullman, 2007). SPSS was used to run the Principal 
Axis Factoring. It is recommended that factor loadings below 0.3 are suppressed (Field, 
2013). 
4. What are the effects of demographic and mood variables on DEX-R and 
DEX-R subscale performance? 
In order to determine whether demographic or mood variables are associated with 
variation in scores on the DEX-R, the study also compared subgroups (e.g. gender) and 
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correlations with continuous variables (e.g. age) with total DEX-R scores and each DEX-R 
subscale. This used Pearson Product Moment Correlation Coefficient. These variables 
included age, gender, years of education, anxiety and depression scores. The GAD-2 and 
PHQ-2 were to be analysed as a continuous measure unless a high proportion scored above 
the established cut off, in which case the groups were to be compared between those 
scoring above and below three. Symptoms associated with depression and anxiety can be 
related to cognitive variability, such as with problem-solving, worry and flexibility. As 
multiple correlations were being used, the Bonferroni correction was applied with the 
alpha level set at 0.01 Regression analysis was used to identify which factors predict 
dysexecutive domains or total score. Gender was the only category variable and was 
converted into a binary variable. Non-parametric tests were used as the DEX-R, GAD-2, 
and PHQ-2 total scores were not normally distributed, and the latter were unable to reach 
normality via transformation. Descriptive statistics were used to explore the frequency of 
participant responses on the items of the DEX-R. 
Results 
Recruitment took place from the 5th July 2019 to the 16th December 2019 where 
140 people participated, of whom 99 completed the test-retest phase, and 60 the validity 
phase. Fifteen participants reported being diagnosed or formally hospitalised for at least 
one of the predefined health conditions. Due to the small number reporting such 
conditions, group comparisons could not be made and they were therefore excluded from 
the analysis (see Appendix M). There were 125 participants included in the analysis (80% 
female) aged between 19 to 69 years (M = 37.7, SD = 12.6), 82% were educated to at least 
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Other white background 
White (Irish) 
Indian 
Other Asian background 
Mixed White and Asian 
Other mixed background 
Black African 













Note. *3 missing data for years of education. Source for categorisations, Office for National Statistics 
1a. Is the DEX-R a reliable measure of dysexecutive problems? 
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The DEX-R had excellent internal consistency with Cronbach’s α at .93 for time 
one and .94 for time two (Hermans et al., 2011). Cronbach’s α were also conducted to 
establish the level of consistency if each item were removed (see table 2). Removal of 
specific items did not yield significant changes to the DEX-R reliability, with α ranging 
from .93 and .94. Split-half reliability was .93 for time one, and .94 for time two. A high 
degree of reliability was found between DEX-R scores on two-time points. The average 
measure ICC was .92 with a 95% confidence interval from .88 to .95 (F(88,88)= 12.4, 
p<.001). The median interval between the two phases were 23 days (interquartile range: 21 
– 28 days). Table 2 displays scores given for the first phase of completion of the DEX-R.  
Table 2. 
Descriptive statistics and internal consistency for DEX-R items and total score 
Item Mean (SD) Item-total 
correlation 
Cronbach’s α if 
item deleted 
1. Impulsivity 1.06 (0.81) r = .38 .93 
2. Prospective memory 1.13 (0.96) r = .60 .93 
3. Apathy 1.14 (0.93) r = .46 .93 
4. Initiation 1.40 (1.10) r = .68 .93 
5. Planning 0.90 (1.02) r = .50 .93 
6. Social disinhibition 1.14 (0.90) r = .56 .93 
7. Intention 1.38 (1.13) r = .65 .93 
8. Verbal aggression 1.98 (0.89) r = -.02 .94 
9. Verbal fluency 1.38 (0.92) r = .54 .93 
10. Anger 1.00 (0.86) r = .43 .93 
11. Perseveration 0.56 (0.85) r = .60 .93 
12. Performance monitoring 0.63 (0.64) r = .43 .93 
13. Abstract thinking 0.62 (0.79) r = .57 .93 
14. Metaworry 1.07 (1.08) r = .60 .93 
15. Lack of concern 0.94 (1.05) r = .17 .93 
16. Blunted affect 1 0.77 (0.91) r = .41 .93 
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17. Working memory 1.03 (0.96) r = .63 .93 
18. Lack of social composure 1.03 (1.02) r = .51 .93 
19. Insight 0.46 (0.81) r = .65 .93 
20. Inertia 0.98 (0.98) r = .47 .93 
21. Temporal sequencing 0.50 (0.79) r = .57 .93 
22. Cognitive control 1.18 (1.04) r = .65 .93 
23. Variable motivation 0.61 (0.85) r = .57 .93 
24. Physical aggression 0.26 (0.66) r = .38 .93 
25. Organisational ability 1.10 (1.09) r = .58 .93 
26. Inability to inhibit responses 0.77 (0.85) r = .59 .93 
27. Confabulation 0.14 (0.35) r = .23 .93 
28. Emotional lability 0.37 (0.67) r = .52 .93 
29. Distraction 1.33 (0.97) r = .65 .93 
30. Restlessness 0.79 (0.81) r = .47 .93 
31. Cognitive confidence 0.73 (0.76) r = .42 .93 
32. Knowing doing dissociation 0.56 (0.77) r = .57 .93 
33. Blunted affect 2 0.75 (0.85) r = .57 .93 
34. Information processing 0.62 (0.90) r = .61 .93 
35. No concern for social rules 0.59 (.874) r = .23 .93 
36. Complex attention 0.89 (0.84) r = .50 .93 
37. Decision making 1.27 (1.09) r = .64 .93 
 
1b. Is the DEX-R a valid measure of dysexecutive problems when compared to an 
existing valid self-report measure? 
 The DEX-R had good concurrent validity when compared to responses given on 
another validated measure of dysexecutive problems, the FrSBe (Grace & Malloy, 2001). 
Both the total scores on the DEX-R and FrSBe were first transformed to achieve adequate 
normality, the correlation between DEX-R and FrSBe was r = .83, p < .01.  
 
2. Does the DEX-R perform as an interval level measure as established by item response 
theory? 
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 The responses on the DEX-R did not show fit to the Rasch model which suggests it 
measures more than one subconstruct (χ2(74, N = 140) = 205.54, p < .001). This is in 
keeping with the aim of the development of the DEX-R to measure underlying 
subconstructs of dysexecutive problems. Differential item functioning using Bonferroni 
correction only yielded differences by gender for one item relating to the expression of 
emotion. Many of the questions showed disordered thresholds, and scale responses were 
not all endorsed on items, therefore it was not possible to confirm the interval nature of the 
scale as these have not yet arrived at a stable solution. Due to the small number in the 
clinical groups, we could not compare the level of endorsement or differential item 
functioning. Upon inspection of the frequency of responses, those at the higher end of the 
scale where dysexecutive problems would be scored as occurring “fairly often” or “very 
often” were rarely rated for many of the items. Twelve of the items were not fully 
endorsed, an additional 10 were only fully endorsed based on the response of one person 
rating “very often” on those items. Confabulation had almost no endorsement, with 100% 
of participants responding as ‘never’ or only ‘occasionally’. Also, performance monitoring 
was not rated by participants as occurring fairly or very often, and 82% of participants 
rated item 24, physical aggression, as ‘never’ occurring. This is consistent with the DEX-R 
being applied to a non-clinical sample. However, despite this being a sample who did not 
report health conditions associated with disruption to frontal functioning, a small number 
of participants did endorse some items as occurring often or very often. Whilst this study 
aimed to recruit a non-clinical sample, there is potential for those amongst an apparently 
‘healthy’ population to endorse behaviours and items that are often attributed to frontal 
impairments. This may in part be due to individual variation, where some participants 
show a lower level of ability, or it may reflect measurement error where the true score lies 
within a wide range of impaired to not impaired. Items which were endorsed as occurring 
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more often included items corresponding to prospective memory, initiation, planning, 
intention, verbal aggression, metaworry, distraction and decision making (Appendix N).  
3. What is the factor structure of the DEX-R in a non-clinical population? Does the 
factor structure align with the Stuss model? 
The parallel analysis retained three factors. The principal axis factoring using the 
oblique rotation resulted in appropriate correlations for this rotation method to be applied 
(Pedhazur & Schmelkin, 1991; Tabachnick et al., 2007). The factor analysis had adequate 
sampling (Kaiser-Meyer-Olkin: .83) and correlation (Bartlett's Test of Sphericity: < 0.01). 
The factor loading matrix is presented in table 3. The three factors accounted for 42.2% of 
the total variance, with the first factor accounting for 31.1%. Items with factor loadings 
below 0.3 were excluded. The internal consistency of factor one was excellent, good for 
factor two and questionable for the third factor (Hermans et al., 2011). As there were only 
three factors, the results, therefore, do not align with the Stuss model of frontal functions. 
The development of the DEX-R found some items did not map onto any of the subscales, 
these were retained due to their clinical utility (Simblett et al., 2017). Therefore, despite 
not all items achieving factor loadings above 0.4, no attempts were made to purify the 
model to preserve this utility.  
Seven of the items cross-loaded onto more than one factor. The 19 items loading 
onto factor one related to those processes associated with the medial/dorsal domain. These 
items spanned across the proposed Stuss subscales, although mainly encompassed those 
from the activation subscale. These factors commonly share themes of initiation, 
maintenance and responsiveness, such as the ability to activate or inhibit a behaviour or 
thought and was therefore labelled as ‘activation-self regulation’. The 17 items loading 
onto factor two appeared to relate to dorsolateral domains, typically these items appear to 
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represent cognitive dysexecutive symptoms such as planning, decision-making, abstract 
thinking, memory and attention. Although it was recognised that both blunted affect items 
additionally loaded onto this factor, and all seven cross-loadings involved this factor. The 
higher factor loadings mainly included those in the proposed executive cognition Stuss 
subscale. This factor was therefore labelled as ‘cognition’. Items loading onto factor three 
related to processes associated with the orbitofrontal areas, these also shared the blunted 
affect items. Additionally, more items corresponded to the Stuss behavioural-emotional 
self-regulation subscale. However, the items also appear to relate to social- self regulatory 
dysexecutive symptoms, therefore this factor was labelled ‘social-emotional’. 
Table 3. 
DEX-R items according to Stuss subscales and EFA with Promax rotation 
Item 
Number 
Stuss subscale according to 
Simblett et al. (2017) 
Item Description 
Factor 
1 2 3 
 
3. Activation Apathy .79 -.26 -.04 
26. Metacognition Inability to inhibit responses .68 -.21 .29 
30. Activation Restlessness .65 -.08 -.08 
11. Activation Perseveration .64 -.15 .27 
32. Behavioural-Emotional Self-
Regulation 
Knowing doing dissociation .64 -.11 .18 
22. Previously metacognition, later 
removed 
Cognitive control .62 .23 -.19 
28. Behavioural-Emotional Self-
Regulation 
Emotional lability .60 .07 -.15 
4. Activation Initiation .59 .25 -.13 
19. Behavioural-Emotional Self-
Regulation (previously Activation) 
Insight .57 -.01 .28 
10. Metacognition Anger .53 -.01 -.09 
25. Executive Cognition Organisational ability .51 .17 -.02 
9. Executive Cognition Verbal fluency .47 .30 -.20 
24. Behavioural-Emotional Self-
Regulation 
Physical aggression .46 .00 -.08 
23. Activation Variable motivation .45 .32 -.18 
7. Activation Intention .44 .34 -.08 
14. Metacognition Metaworry .40 .29 -.01 
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37. Activation Decision making .40 .38 -.08 
6. Metacognition Social disinhibition .34 .23 .10 
21. Executive Cognition Temporal sequencing .32 .15 .25 
27. Behavioural-Emotional Self-
Regulation 
Confabulation .28 .06 -.12 
13. Executive Cognition Abstract thinking -.10 .84 -.10 
5. Executive Cognition Planning -.07 .76 -.16 
36. Executive Cognition Complex attention -.08 .64 .05 
31. Metacognition Cognitive confidence -.07 .61 -.07 
17. Executive Cognition Working memory .12 .56 .07 
29. Executive Cognition Distraction .19 .54 .01 
20. Behavioural-Emotional Self-
Regulation 
Inertia -.09 .52 .16 
33. No subscale Blunted affect 2 -.10 .49 .41 
2. Previously Executive Cognition, 
later removed 
Prospective memory .15 .48 .08 
12. Activation Performance monitoring -.07 .36 .33 
1. Metacognition Impulsivity .02 .33 .14 
18. Metacognition Lack of social composure .11 .30 .29 
35. Metacognition No concern for social rules -.20 .01 .69 
15. Behavioural-Emotional Self-
Regulation 
Lack of concern .04 -.11 .39 
16. Behavioural-Emotional Self-
Regulation 
Blunted affect 1 -.06 .30 .37 
8. Behavioural-Emotional Self-
Regulation 
Verbal aggression -.21 -.05 .37 
34. Executive Cognition Information processing .19 .26 .37 
Eigenvalues 10.93 1.48 1.38 
% of variance 31.12 5.69 5.14 
Cronbach’s α .92 .88 .68 
Note. Factor loadings > .30 are shown in bold 
4. What are the effects of demographic and mood variables on DEX-R and DEX-
R subscale performance? In particular, what are the effects of age on DEX-R 
and DEX-R subscale performance? 
Demographic details of the participants are detailed in table 1. Pearson Product 
Moment Correlation Coefficient analysis was conducted to establish any influence on 
participants reports of dysexecutive problems. Gender (r = -.02, p = .836) and years of 
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education (r = -.52, p = .551) were not significantly correlated to DEX-R total and factor 
scores (p>.05). No significant differences were found between males and females t(123) = 
-.208, p = .84. A negative correlation was found between responses on the first DEX-R 
administration and age (r = -.27, p = .002). Age significantly correlated with factor one, r = 
-.34, p = <.01 and factor two r = -.24, p = <.01, but not with factor three, r = .03, p = .76. A 
cut off of three as specified by the literature for the GAD-2 and PHQ-2 indicated 18% of 
participants scoring above the anxiety threshold, and 7% scoring above the depression 
threshold. Due to the uneven group sizes correlation analysis was used to preserve validity. 
Spearman Rho correlations was applied when analysing the PHQ-2 and GAD-2. Anxiety 
scores correlated with dysexecutive problems, r = .45, p = <.01. Depression scores were 
moderately correlated to dysexecutive problems, r = .58, p = <.01. The scores on the GAD-
2 significantly correlated with factor one, r = .51, p = <.01 and factor two r = .47, p = <.01, 
but not with factor three, r = .16, p = .16. Whereas, the scores on the PHQ-2 significantly 
correlated with all the factors, factor one, r = .57, p = <.01, factor two r = .45, p = <.01, 
and factor three, r = .25, p <.01. 
The effect of background variables on DEX-R responses was analysed using a 
multiple regression, the DEX-R total score was the dependent variable, and age, gender, 
GAD-2 and PHQ-2 scores were the independent variables. In model one, age and gender 
were kept constant and explained 9.5% of the variance whereas in model two the 
additional inclusion of the GAD-2 and PHQ-2 scores explained 31.9%, F(4,120) = 14.05, p 
< .001. The results found gender not to significantly predict DEX-R scores (p >.05). In the 
first model, DEX-R scores decreased by .44 for every year older a participant was, 
however when the model also accounted for mood, this decreased to a reduction of .17 for 
every year older but was no longer a significant effect. Controlling for age, gender, anxiety 
and depression scores, the regression coefficient (B = 2.51, 95% CI (0.21, 4.81) p < .05) 
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for the GAD-2 indicates that for each increased score on the GAD-2, the total DEX-R 
score will increase by 2.51. Furthermore, within the same model, the regression coefficient 
(B = 5.28, 95% CI (2.67, 7.88) p < .05) for the PHQ-2 indicates that for each increased 
score on the PHQ-2, the total DEX-R score will increase by 5.28. 
Discussion 
The research aimed to assess the psychometric properties of the DEX-R with a non-
clinical sample. The DEX-R was demonstrated to be a valid measure when compared to an 
already validated measure of dysexecutive problems, the FrSBe. Also, the DEX-R was 
reliable, evidenced by its high internal, test-retest and split-half reliability.  
The individual variability of dysexecutive problems in a non-clinical population 
supports previous research (Chan, 2001). The influence of demographic factors and mood 
were also explored, with age and mood found to significantly correlate with the DEX-R as 
has previously been found in the literature with the DEX and the DEX-R (Dimitriadou et 
al., 2018; Shaw et al., 2015). Age negatively correlated with the DEX-R, indicating that 
older participants reported less dysexecutive problems. This is inconsistent with wider 
literature that cognitive functions associated with prefrontal areas decline with normal 
ageing (Van Petten et al., 2004; West, 1996). This is likely to be due to the sample 
demographics, with the oldest participant being 69 years old and only 11% were aged over 
56 years of age. The effect of age seemed to be removed when incorporating mood into the 
model, linking somewhat to previous research where negative affect mediated responses of 
dysexecutive problems reported by younger people (Gerstorf et al., 2008). These findings 
could be due to the younger age of the sample and explained by theories of brain 
maturation, with prefrontal areas developing into people’s early 30’s (Barkley, 2012; 
Coffman, 2014). The ventromedial areas of the prefrontal cortex are known to mature later 
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than other regions and are implicated in social and emotional functions, and may therefore 
be less developed in this sample (Burnett et al., 2009; Gerstorf et al., 2008; Pfeifer et al., 
2011; Sebastian et al., 2011). Furthermore, the demographics of the sample which are 
predominately younger, white and female are known to have increased prevalence of 
anxiety levels (Jenkins, Ducker, Gooding, James & Rutter-Eley, 2020). This might 
contribute to the correlations with symptoms of anxiety and depression. Although the 
current study’s reported prevalence is lower than that reported in the literature, with 18% 
scoring above the anxiety threshold and 7% above the depression threshold. 
The Rasch analysis evidenced the DEX-R as being multidimensional, supporting its 
development to capture underlying subconstructs of dysexecutive problems (Simblett et al., 
2017). A factor analysis found three factors representing activation- self regulatory, 
cognitive and social-emotional functions. When compared to the proposed Stuss subscales, 
the factors appeared to share some overlap with the ‘activation’, ‘executive cognition’ and 
‘behaviour-emotional self-regulation’ subscales, most notably activation with the first 
factor leading to the shared label ‘activation’, however also encompassing self-regulatory 
items. Those items corresponding with the ‘metacognition’ subscale appeared to be equally 
distributed across the three factors, which may relate to the application with a non-clinical 
sample. Despite the results not aligning fully with the Stuss model, the three factors do 
appear to have some overlap with theoretical conceptualisations of frontal lobe 
functioning. All the subscales correlated with symptoms of depression, albeit only a 
weaker correlation for the social-emotional factor. Only the activation-self regulatory and 
cognition factors correlated with symptoms of anxiety. The social-emotional factor may 
therefore represent reduced emotional reactivity or neutrality, such as those items loading 
onto it including both blunted affect items, a lack of concern and no concern for social 
rules. Furthermore, the cognitive factor correlations may be driven by those executive 
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cognitive factors associated with depression and anxiety, such as difficulties with problem-
solving and decision making, and working memory. The activation-self regulatory factor 
may correlate with symptoms of depression and anxiety as they account for components of 
apathy and a lack of motivation. Therefore, individual differences found in the study, 
particularly the different components forming factor one, may reflect an overlay with the 
cognitive symptoms of depression such as apathy. The issue in determining overlap and 
directionality of mood and dysexecutive problems is further complicated by the lack of 
diversity in the sample. The demographics of the sample are reported to experience a 
higher incidence of anxiety (Jenkins et al., 2020). It may be that particular items on the 
DEX-R are more likely to be rated as occurring more frequently in those experiencing 
symptoms of anxiety or depression, such as working memory, problem solving and 
decision making as previously noted. This might account for why DEX-R scores increased 
by two for every GAD-2 score, and by five for every PHQ-2 score. In terms of age, the 
later maturation of the prefrontal areas associated with social and emotional variations in 
those under the age of 30 has already been discussed. It is recognised that any construct 
will show some individual variation, and the distributions of scores will share some 
overlap between clinical and non-clinical groups.    
The DEX-R was initially developed to map on to the Stuss model. Both the self and 
informant report versions have demonstrated validity and reliability in both acquired brain 
injury and healthy ageing samples (Dimitriadou et al., 2018; Simblett et al., 2017). The 
current study adds to the literature regarding the robustness of the psychometric properties 
of the DEX-R by evidencing its stability and consistency over time. Additionally, it 
extends upon the previous literature by comparing to a dysexecutive measure validated in 
non-clinical and clinical groups, evidencing concurrent validity of the DEX-R. 
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Furthermore, its application with a non-clinical population provides some consideration for 
clinicians on how individual differences and mood may contribute to responses.  
The DEX-R mapped on to the Stuss model when applied to a brain injury group, 
with four subscales supporting the theoretical domains of metacognition, activation, 
executive-cognition, and behavioural-emotional regulation (Simblett et al., 2017; Stuss, 
2007). Its application in a healthy ageing and a bipolar sample instead yielded three factors 
(Social Self-Regulation, Motivation and Attention, and Flexibility, Fluency and Working 
Memory). Both authors report these factors were in line with Fuster’s (2008) theory, which 
outlines the role of three prefrontal circuits (orbitofrontal, anterior cingulate and 
dorsolateral) in cognitive and emotion frontal processes. The current study supported 
previous research on the DEX-R being multidimensional, and factor analysis yielded three 
factors more in line with this research. However, a confirmatory factor analysis would be 
required to confirm fit to the model.  
The differences in the underlying subscales and subconstructs found within the 
DEX and DEX-R may relate in part to the clinical population of which they are applied to, 
as it is well understood that such difficulties are noted in neurological, neurodevelopmental 
and mental health conditions. The frequency of responses shows two-thirds received a full-
range of responses, however, this reduced to 40% where more than one individual rated 
each response. The items likely have different meanings to people, which in part may 
relate to the presence of clinical factors. A comparison of the endorsement of items against 
clinical groups could provide insights into those more highly rated by clinical groups. 
Those who score highly on the less endorsed items may more likely indicate a problem 
beyond individual variation. Attempts were not made to purify the model using Rasch 
techniques in order to retain the clinical utility of the DEX-R. 
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Strengths and Limitations 
A limitation of the current study is the highly educated and largely white and 
female sample, this limits its generalisability more widely in terms of how well the 
measure performs across diverse groups. This skew in the sample means how well the 
DEX-R performs with less well educated, non-white, male populations cannot be 
commented on here. This poses limitations for clinicians working with these groups as the 
psychometrics of the measure reported are based on the homogeneous sample, restricting 
its application. Given the scope of the research was to measure dysexecutive problems, a 
limitation is that those with such difficulties might be less likely to enrol in taking part in 
the online study. This limits the representativeness of the sample as the nature of these 
difficulties such as, for example, ‘energisation’ abilities which involve the activation and 
initiation of behaviour may mean they are less motivated to volunteer in online research 
(Stuss, 2011). Furthermore, the study therefore cannot contribute to previous research on 
individual variation of reported dysexecutive problems relating to education level (Faria et 
al., 2015; Foss et al., 2013). The secondary research question relating to healthy ageing 
was challenging to measure due to the small number of participants over the age of 60, as 
research on healthy ageing typically indicates less change prior to this age. The study 
would have benefited from including additional questions on demographic variables, such 
as occupation and lifestyle (e.g. alcohol consumption and smoking status) as these can 
contribute to variability in neuropsychological abilities (Fisher et al., 2014; Glass et al., 
2009). 
The use of a survey to administer the rating scales may be influenced by survey 
bias due to the self-reporting of behaviour, cognition and mood. To overcome this, 
participants were not required to give their personal details and by doing it online it was 
hoped this would reduce such bias. A forced-response option was applied to the survey to 
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ensure there was no missing data. This was because missing data would have meant 
participants data could not be used. Nevertheless, the use of forced responses in survey 
research can increase reactance (Stieger, Reips & Voracek, 2007). Suggestions to mitigate 
reactance include removal for the requirement to include personal information and by 
providing a ‘degree of autonomy’. This autonomy can be applied via the requirement to 
manually take part in the survey, rather than a freely accessible one. A strength of the study 
is the use of such a manual login, which has been additionally found to lead to increased 
quality of data (Heerwegh & Loosveldt, 2002).  
The current study measured constructs which incorporate factors which could be 
impeded by dysexecutive factors, such as motivation and apathy. An email reminder was 
used to prompt and remind participants of the study. The use of a survey was beneficial in 
applying the test-retest phase, as this could be distributed via a second survey, rather than 
individuals being required to follow-up themselves. A potential confound could have been 
that those who are more well planned and organised would be more likely to complete this 
phase, therefore the control of this confound is a strength of the study. There is not a 
universal standard on the timeframe for test-retest reliability. The requirement is for it to be 
long enough for memory to not confound results, and not too long that other factors 
account for responses (e.g. rehabilitation, neurodegeneration). A three-week interval has 
been applied in similar research (Cummings et al., 1994; Gioia et al., 2000; Holst & 
Thorell, 2018) and was suitable for the constraints of a doctoral thesis. The correlation 
between the results were high to indicate reliability, as they were not perfectly correlated 
this indicates it is less likely memory dictated responses. 
Questions relating to health were included as part of the study to allow for 
monitoring whether clinical factors explained variance in the data, should this have arisen. 
Unfortunately, only limited data from clinical groups were received and they were 
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therefore excluded from the analysis. However, consent was gained to retain their data for 
future analysis, which could be used in studies directly recruiting such clinical groups.  
Clinical implications 
The use of rating scales enhances the assessment of dysexecutive problems in 
capturing everyday experiences of individuals, which are not necessarily measured by 
neuropsychological tests alone (Malloy & Grace, 2005). For example, the BADS was 
found to correlate with the behaviour and cognition factors, but not the emotion factor on 
the DEX. The factors in the current study appear to capture emotional processes well and 
may particularly relate to emotional regulatory models (Salas, Gross & Turnbull, 2019). 
Furthermore, the correlations with depression scores may indicate the measurement of 
apathy. The psychometric properties of the DEX-R have previously been assessed with 
ABI, bipolar disorder and healthy ageing samples. The current study used a non-clinical 
sample which highlighted how age and mood can influence responses on the DEX-R. In 
regard to the decrease in reports of dysexecutive problems with increased age in a normally 
distributed sample, this has implications for clinicians to consider theories of prefrontal 
brain maturation into their assessments and interpretations. Such as considering how social 
and emotional functions might be less developed in younger people and adapting 
neurorehabilitation strategies with this in mind. A further finding was the presence of 
behaviours typically attributed to dysexecutive problems in clinical settings also occurring 
in a non-clinical sample. Certain items were more highly rated than others indicating that 
individual variation is found not just in clinical groups. This individual variation has 
implications for clinicians in their interpretation of assessment scores, such as an 
awareness that this natural variation in scores on these items may have been present prior 
to clinical diagnosis. Therefore, clinicians would need to be mindful in not immediately 
concluding that someone has a dysexecutive impairment if a score on an item might be 
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common in the general populations. A further clinical implication is the inclusion of mood 
scales in their assessments and to consider health factors in such interpretations.  
Future research 
The current study focused on reports of dysexecutive problems in a non-clinical 
population, and there was a lack of endorsement for some of the items. Future research 
could consider a comparison to clinical groups on how responses differ between clinical 
and non-clinical groups via differential item functioning. Additional investigation via a 
Rasch analysis could establish subscales, which may highlight differences between groups 
such as whether awareness and metacognitive processes are more applicable to those with 
prefrontal brain injuries. Finally, engaging with participants from different ethnic groups 
and a range of educational backgrounds could be made to improve the generalisability of 
findings.  
Conclusion 
The current study supports the psychometric properties of the DEX-R as found in 
previous research, being both a valid and reliable measure of dysexecutive problems. The 
number of factors had similarities with two previous studies. There was individual 
variation in responses, influenced somewhat by mood and age. This may have implications 
for clinicians in their interpretation of DEX-R scores. Future research could consider 
comparing the responses of clinical and non-clinical groups.  
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This extended methodology chapter provides supplementary information regarding 
the empirical paper including, sample size and power calculations, measures, procedure, 
ethical considerations and analysis.  
Sample size and power calculations 
Two approaches were used to estimate the required sample size for each analysis. 
This included reviewing the research literature and calculations conducted using the 
computer package G* Power 3.1.9 (Faul & Erdfelder, 1992). 
Calculations using G*Power: 
Questions relating to validity, test-retest reliability, mood and demographic factors 
were answered using correlational analysis. G* Power analysis determined 109 participants 
were required with sufficient power of 0.9, to detect a medium effect size, or 64 
participants if power were set to 0.8. For multiple regression analysis, G* Power output 
indicated 82 participants were required, again for a medium effect size to be detected with 
power set at 0.9 with four variables included in the model. Probability for both of these 
were set at .05.  
Recommendations from the literature:  
Internal reliability: A sample size of at least 30 participants are recommended when 
using a single Cronbach’s alpha coefficient (Bujang, Omar & Baharum, 2018).  
Rasch analysis: For a Rasch analysis, a sample size of 243 is acceptable based on 
consultation of the literature suggesting parameters for sample size based on 99% 
confidence (Linacre, 1994). Pilot Rasch analysis has been conducted with samples sizes of 
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at least 100 participants (Simblett et al., 2017). It is recommended that at least 100 
participants are required to avoid disordering parameters (Chen et al., 2014).  
Factor analysis: The literature recommends a sample size of at least 50 for 
exploratory factor analysis (de Winter, Dodou, & Wieringa, 2009). SPSS calculates the 
Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy which indicates whether factor 
analysis is appropriate with the amount of data, and therefore whether an increased sample 
size is required. A KMO above 0.7 is classed as ‘good’, above 0.8 is ‘great’, and those 
above 0.9 are ‘superb’ (Field, 2013; Hutcheson & Sofroniou, 1999). 
Measures 
Full copies of the DEX-R and FrSBe are not provided in the thesis portfolio as they 
are subject to copyright. The additional 14 questions included in the DEX-R are reported in 
the literature (Simblett et al., 2017). Permission was required to use the FrSBe and DEX-R 
for research purposes, license agreements between authors and Pearson and PAR can be 
found in the appendices (Appendix K and L).  
Procedure 
Qualtrics survey software hosted the research, a three-year license was granted to 
the researcher by the University of East Anglia. Due to the included measures being 
subject to copyright, the license for use required the online survey be password protected, 
and for participants to be emailed the link with the password. A forced response option was 
applied to the questionnaire in order to limit missing data or errors. Where participants 
partially completed the research, this data was recorded by Qualtrics. Data was first 
downloaded on to Excel where these incomplete datasets were removed. Data was then 
paired for participants who took part in the test-retest reliability phase, however errors in 




Detailed information about the study was provided on the participant information 
sheet which detailed the aims and purpose of the study to allow for informed consent.  
Risks and benefits from taking part 
The study took no longer than 30 minutes to complete and was, therefore, hoped 
that no psychological distress would arise from the study. The participant information 
sheet detailed that should participants have concerns following the nature of the 
questionnaire, such as memory or emotional difficulties, they could discuss this with their 
General Practitioner. Participants were informed that dysexecutive problems are reported 
in non-clinical populations to allow normalising their responses to questions. 
Right to withdraw 
 Participants were made aware that they could withdraw from the study by exiting 
the survey. The participant information sheet highlighted that due to the data being 
anonymised, once they have completed the survey their data would not be able to be 
removed. They were made aware they could contact the researcher should they wish to 
withdraw from the second phase of the study as the researcher would stop the reminder 
email from being sent out through Qualtrics.  
Confidentiality 
Participants were assigned with a participant code to ensure confidentiality was 
upheld. The only personal detail collected was an email address to send the link to the 
study online and for the test-retest phase which did not form part of the analysis. Email 
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addresses were stored separately from the anonymised research data and were password 
protected.  
Data Protection 
Guidance from the Data Protection Act and The General Data Protection 
Regulation (GDPR) (EU) 2016/679 were followed. In line with UEA data protection 
policy, anonymised study data will be archived by UEA for 10 years after the study ends, 
after which it will be destroyed. 
Analysis 
            Test-Retest reliability 
            Psychometric research traditionally uses Pearson’s correlation to determine 
consistency over time. However, limitations have been raised due to its theoretical 
standpoint of measuring relationships between different variables. Therefore, in the case of 
test-retest reliability it was determined as not appropriate to use due to this method 
measuring the relationship between the same variable (Yen & Lo, 2002). Additionally, 
when applied in these cases Pearson’s correlation lacks the ability to detect systematic 
errors. Yen and Lo (2002) suggest using intra-class correlations to limit these issues and 
was therefore the measure used for test-retest reliability in the current study.  
Factor Analysis 
Different methods were considered to decide on the approach to take on 
determining the number of factors to extract. The default option in SPSS is the mostly 
commonly reported method where factors with eigenvalues greater than one are retained 
(Kaiser, 1960). However, it is argued that the retention of factors above eigenvalues of one 
is arbitrary, and that this method can overestimate the numbers to retain due to reporting an 
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upper bound, despite interpretations of this method being on reporting exact numbers to 
retain (Hayton, Allen & Scarpello, 2004). Another method considered was using a scree 
plot of eigenvalues to identify the point of inflexion, extracting those above this point 
(Cattell, 1966). The literature specifies that this method is more reliable in samples above 
200 participants, and therefore was not appropriate for the current study due to the samples 
size being below this (Stevens, 2002). Parallel analysis was the final factor retention 
method considered (Horn, 1965). This compares two sets of data, the eigenvalues of 
randomly generated data with the actual data eigenvalues. Those factors where eigenvalues 
are above the 95th percentile of the randomly generated data are extracted (Çokluk & 
Koçak, 2016). Hayton, Allen and Scarpello (2004) describe it as the most precise method 
for factor retention, and it was deemed the most appropriate method for the current study.  
Additional analysis 
            Further exploratory analyses were conducted which were secondary to the research 
questions outlined in chapter 3. These included analyses using the test-retest reliability 
data, the FrSBe subscales and comparison of groups. The results of which can be found in 

















 Additional exploratory analyses were conducted beyond the scope of the empirical 
paper, and therefore were not included in chapter 3. These are instead reported here and 
include analyses using the DEX-R responses collected from the test-retest reliability phase, 
the FrSBe subscales, and the comparison of groups. 
Additional demographic and mood correlations 
 Correlations calculated between the first administration of the DEX-R and 
demographic factors are reported in chapter 3. These were repeated for the DEX-R 
responses collected during the test-retest phase. Table 1 compares these, and the 
relationships found from the analysis using the first administration of the DEX-R were 
replicated. 
Table 1.  
DEX-R relationship with Age, Education and Gender  
  Age Years of 
education 
Gender GAD-2 PHQ-2 
DEX-R, 
time 1 
r -.27 -.05 -.02 0.45 0.58 




r -.29 -.03 -.16 0.41 0.49 
(n = 89) p .006 .770 .138 <0.01 <0.01 
 
Additional validity analysis 
 The FrSBe subscales were correlated against the three DEX-R factors extracted, all 
correlations were significant and are detailed in table 2.  
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Table 2.  
Comparison between FrSBe subscale scores and the three DEX-R factors generated (n = 
53) 








r .65 .75 .41 
p .000 .000 .002 
FrSBe Apathy 
r .68 .60 .35 
p .000 .000 .011 
FrSBe 
Disinhibition 
r .68 .64 .66 
p .000 .000 .000 
 
Clinical Variables 
 Only 15 participants reported a health condition which could potentially influence 
responses on the DEX-R. Due to the small sample, discriminant analysis could not be 
computed. However, when comparing scores between the two groups, those with a 
reported health condition scored significantly higher on the DEX-R (Mdn = 42) than those 
without a health condition (Mdn = 30) (U=635.500, p=.042). There was also a significant 
difference in the DEX-R scores for those scoring above (Mdn = 47) and below (Mdn = 26) 
the cut off on the GAD-2 (U = 682.500, p = .000), and above (Mdn = 52) and below (Mdn 
= 29) the cut off on the PHQ-2 (U = 359.000, p = .049). Further small-scaled analysis was 
conducted using the data retrieved from those reporting a health condition. These 
participants were matched with a non-clinical counterpart based on age, gender, ethnicity 
and education level. This matching was only achievable for 13 of these participants, 
however, this analysis found no significant differences in DEX-R scores between those 
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reporting a health condition (Mdn = 35) compared to the matched controls who did not 
report a health condition (Mdn = 21) (p = .113). Therefore, once demographic factors were 
controlled for these apparent differences between the clinical group and the rest of the 
sample were no longer found. These differences in scores may be attributable to 
demographics, however, all of these analyses would benefit from larger sample sizes to 
















































Overall discussion and critical review 
 
 This final chapter of the thesis portfolio will summarise and appraise the findings 
from the systematic review and the main study. Wider clinical implications and 
considerations for future research will then be explored. Finally, the chapter will close with 
final conclusions. 
Main findings 
 The thesis portfolio intended to explore the measurement of frontal functions in 
clinical and non-clinical populations. The systematic review identified various rating scales 
of executive function used across differing clinical and non-clinical groups. The DEX was 
the most widely used rating scale and additional papers were retrieved where modifications 
to the DEX had been made. These had good psychometric properties across different 
groups but there were inconsistencies in the factors reported. The DEX-R was found to be 
a multidimensional measure with both an ABI and healthy ageing sample. Previous 
measurement of the validity of the DEX-R were limited in not comparing it to an already 
validated measure and assessing consistency over time could strengthen its reliability. 
Individual variation with non-clinical groups has been found previously (Chan, 2001). 
 The empirical paper therefore sought to address these gaps by establishing the 
psychometric properties of the DEX-R in a non-clinical population. The DEX-R was 
determined to be a valid and reliable measure of dysexecutive symptoms. The Rasch 
analysis confirmed the multidimensionality of the DEX-R. A three-factor structure was 
found, in line with two previous studies on the DEX-R. This included an activation-self-
regulatory factor, cognitive factor and social-emotional factor. Factors relating to initiation, 
cognition, and self-regulation were widely reported in the systematic review with non-
clinical samples. The DEX-R when used with a non-clinical population shared some 
overlay, but did not fully align with, the Stuss model.  
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  There were individual variations found in reports of dysexecutive problems in the 
non-clinical population, in line with previous research (Chan, 2001). Mood, notably 
symptoms of depression, correlated more so with higher DEX-R scores. Additionally, 
younger age was associated with increased reports of dysexecutive problems, again 
consistent with the literature (Gerstorf et al., 2008). These associations were replicated 
when the correlations were repeated using the DEX-R responses from the test-retest phase. 
Weaker correlations of symptoms of depression and anxiety were found for the social-
emotional factor and appeared to relate more so with neutrality of emotions, such as 
blunted affect. Papers included in the systematic review were selected based on their 
reports of psychometric properties, some additionally included analysis relating to mood. 
Shaw, Oei and Sawang (2015) reported similar correlation co-efficients as the empirical 
paper for depression and the DEX, although they found greater associations with anxiety 
measures. Additionally, they found those with a diagnosed depressive or anxiety condition 
scored significantly higher on the DEX compared to a non-clinical sample. Five papers in 
the systematic review included samples with mental health conditions, where the number 
of factors ranged from two to three. Across papers the rating scales capture behavioural 
and emotional processes, going beyond the traditional focus of measuring mainly cognitive 
difficulties reported (Chan et al., 2008; Damasio, Tranel & Damasio, 1991; Stuss, 2007). 
The systematic review highlighted how decision making and initiation factors were more 
present in non-clinical samples, in the empirical paper these were two of the most endorsed 
items of the DEX-R with a non-clinical sample. When considered with the correlations of 
symptoms of depression, these factors may represent the cognitive aspects of these 
symptoms. Furthermore, the systematic review consistently found that inhibition was not 
widely reported in non-clinical samples and did not form part of the factor descriptions in 
the empirical paper when a factor analysis was applied with a non-clinical sample. 
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Individual differences therefore perhaps contribute to the variance influencing performance 
in neuropsychological tests (Miyake & Friedman, 2012). The conceptualisation of these as 
a “syndrome” is also further challenged due to the varied responses on the DEX-R in both 
papers (Damasio et al., 1991). 
Strength and limitation of the thesis portfolio 
 Both the systematic review and empirical paper contribute to the literature on the 
measurement of frontal functions. They both extend on the understanding that the variation 
in symptoms goes beyond clinical groups, with such individual variability being found in 
non-clinical groups. Both papers included a consistent and standardised interpretation of 
the psychometric properties (Hermans et al., 2011). A limitation of the empirical paper and 
that of those in the systematic review using non-clinical groups, were that these often-
included individuals with a higher level of educational attainment, were mostly white and 
female. This limits the generalisation of findings to a more diverse population as it is 
important to consider how well measures perform across diverse groups.  
 It had been hoped that this thesis would contribute further on the conceptual nature 
of frontal functions. However, this was difficult due to the complexities of analysing 
psychometrics and differences in the methods used, the varied labels of the factors, and the 
variation found across samples. The Stuss model was predominately considered, 
particularly with its relevance to the DEX and DEX-R. There is a usefulness in considering 
the unity and diversity of frontal functions further, such as predictions when using 
measures with clinical groups with particular patterns of neurological injury.  
 Constraints relating to the completion of such a study as part of a doctoral training 
programme meant that funding limited the amount of FrSBes which could be purchased for 
use, and the time frame for test-retest reliability was reduced (albeit still acceptable given 
similar literature including those in the systematic review). The quality of the empirical 
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paper would have been improved if all participants completed the FrSBe, as outlined by 
the QUADAS-2. The power analysis indicated a minimum of 64 participants for 
correlation analysis. This was reached for the test-retest reliability analysis, mood and 
demographic correlation analyses, however not for the validity analysis where 54 
participants were included. The sample size for the multiple regression and pilot Rasch 
were achieved. The factor analysis sample size was classed as ‘great’ based on the KMO 
(Field, 2013; Hutcheson & Sofroniou, 1999). Unfortunately, there were delays experienced 
during the ethics process and whilst obtaining the budget. This reduced the expected data 
collection time which could have focussed on recruiting a more balanced and 
representative sample. 
A strength was conducting the concurrent validation analysis as recommended by 
papers in the systematic review (Shaw et al., 2015). Additionally, a strength is that the 
systematic review supported the use of the FrSBe as a validated alternative to be used as 
part of assessing the DEX-Rs validity. However, one of the papers found that the 
disinhibition scale on the FrSBe was the only one valid in a non-clinical population 
(Caracuel et al., 2012). This was because the apathy and executive dysfunction scales were 
not classed as unidimensional, and therefore in non-clinical groups may capture different 
processes. Unfortunately, the empirical paper did not receive a large enough clinical 
sample to explore these differences further. Those participants who regrettably were 
excluded from the analysis on this basis did provide their consent for their data to be used 
as part of future research, the scope of which could specifically address clinical 
comparisons. Although age and mood showed interesting correlations, these were not 
explored in greater detail as the focus of the thesis portfolio was in regard to psychometric 
properties. A strength based on the findings from both papers, is the applicability of rating 
scales measuring frontal functions beyond cognitive factors. The factor analyses across 
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papers highlight how underlying subconstructs capture a broad picture of challenges 
reported, additionally encompassing social, emotional and behavioural processes. 
Furthermore, the cross-loadings of seven items across factors show some association 
between factors, which may reflect the unity and diversity previously reported (Miyake & 
Friedman, 2012). These findings demonstrate the utility of rating scale measures as part of 
neuropsychological testing, with clinical benefits to capture specific difficulties and being 
able to tailor interventions most appropriate for a person. The clinical use of both 
standardised neuropsychological tests and rating scales together can enhance assessment, 
and address the gap previously identified in capturing social-emotional process to improve 
ecological validity (Chan et al., 2008). Additionally, in the current context whereby social 
distancing measures are in place, the methods explored in the thesis may contribute to 
identifying valid and reliable methods which could be conducted remotely.  
The systematic review demonstrated how informant versions of the rating scales 
further enhances assessment and has additional benefits where individuals may have 
reduced awareness of their difficulties. The empirical paper did not explore this further; 
informant reports were not included due to the scope of the research being conducted as 
part of a doctoral thesis online. Hosting the study online produced its own challenges and 
opportunities. The hope was that this would enable a more representative sample to take 
part as the study could reach more widely. The use of an ID code provided anonymity; 
however, some responses could not be used as they did not match at the retest stage.  
Many psychological measures apply statistical analyses appropriate to interval 
levels of measurement, despite many of these actually being ordinal. Rasch analysis was 
applied in papers using the DEX-R retrieved in the systematic review which indicated it 
performed as an internal level of measurement. However, the empirical paper was unable 
to replicate these findings due to the limited endorsement of item responses, again the 
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implication being the inclusion of clinical groups to achieve such endorsement. Rasch 
analysis is also concerned with the relationship between item difficulty and person ability 
(Bond, 2015). Therefore, further analysis using item response theory could explore the 
extent to which items may perform differently between clinical and non-clinical groups to 
further understand the variation in likelihood of rating at certain levels across items as 
found in the frequency of responses in the empirical paper.  
Papers differed as to whether an oblique rotation or orthogonal rotation was applied 
in a factor analysis, depending on whether the authors felt the factors should, or should not 
be correlated with each other. Furthermore, papers contrasted in whether correlated factors 
evidenced construct validity. One paper reports the correlation found did therefore 
demonstrate construct validity (Dimitriadou et al., 2018), whereas a separate paper used 
the lack of correlation to also indicate construct validity (Shaw et al., 2015). It would be 
expected that the factors would have some correlation as they are measuring the same 
underlying construct. Guidance from the literature was sought in order to base the decision 
on best standards. The empirical paper did find the three factors correlated, and therefore 
the rotation was applied.  
Clinical implications 
 Both papers report upon the psychometric properties of different rating scales, and 
how these translate across different clinical groups. The systematic review presents the 
differences by clinical group, which can support clinicians in identifying the measure most 
relevant to their clinical setting. In addition, these papers highlight the individual 
variability in non-clinical groups that can arise due to age or mood, for example. The 
implications for clinicians are holding these variations in mind in their interpretation of 
scores. The papers retrieved in the systematic review mostly appeared to view it as a 
multidimensional construct, with different rating scales captured these underlying 
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constructs through the use of subscales. The empirical paper supported the idea of 
multidimensionality, and contributed to the three-factors as reported in other papers of the 
DEX-R. The DEX-R was developed to capture the four processes in the Stuss model for 
those with ABI. Perhaps the different factors reported in this paper and others are due to 
the different groups these have been applied with. The questions likely have different 
meanings to different people, and the level at which they impact on everyday life. This was 
reflected in the lack of endorsement of many items in the empirical paper. Different items 
on the DEX-R correspond to different subconstructs, as individual variability is known in 
both clinical and non-clinical groups the use of subscales can guide clinicians to 
individualised interventions, for example, prompting, goal-management, and emotional 
regulation strategies. Furthermore, assessment may identify a presence of a deficit 
compared to what would be expected in a non-clinical group which may contribute to 
diagnosis. Also, in guiding rehabilitation in formulating why a person is having difficulty 
in everyday life tasks to improve performance, as well as uses as an outcome evaluation.  
Future research 
 The systematic review included papers where responses on rating scales were 
compared between clinical and non-clinical groups. The empirical paper added to the 
current literature on the DEX-R by exploring its psychometric properties and factor 
structure with a non-clinical sample. Previous research utilising the DEX-R has included 
samples of people with ABI, bi-polar disorder and an exploration of healthy ageing. Future 
research could compare clinical and non-clinical groups, to further understand variation in 
factor scores in accordance with underlying neurological networks of specific clinical 
disorders. This would further support clinicians to be able to select the most robust 
measure applicable to their setting. The systematic review highlighted only three papers 
assessing classification of clinical conditions. One paper attempted a discriminant analysis 
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correctly classifying a non-clinical and psychiatric group, but not the neurological group . 
Shaw et al. (2015) does not outline whether this neurological group includes those with or 
without frontal deficits (or both). The mental health group may therefore be less diverse 
representing a common difference in cognitive functioning compared to the non-clinical 
group. Shaw et al. (2015) recommended further research assess the discriminative ability 
of the DEX. Since revisions to the DEX have since been made, leading to the development 
of the DEX-R, this may mean improvements are more sensitive to classifying different 
clinical groups. The empirical paper did not achieve an adequate sample size to conduct 
such an analysis, therefore recommendations are made for future research to consider this 
further. 
Conclusion 
 The different models and measurement of frontal functions has led to the use of 
rating scale measures to enhance clinical assessment, by their ability to gain everyday 
experiences of people and the challenges which they may experience. The systematic 
review mostly reported on the robustness of psychometric properties in the DEX and its 
variants, the BRIEF-A and the FrSBe. The DEX-R was developed to map on to conceptual 
frameworks and the empirical paper applied it with a non-clinical sample expanding on its 
reported reliability, validity and factor structure. Further development of the DEX-R could 
compare clinical and non-clinical groups to understand differences in endorsement of 
response, further adding to the robustness of the measure. This could consider whether 
those behaviours typically understood to indicate frontal dysfunction may not only arise 
due to frontal brain injury. This has important implications when interpreting responses on 
rating scale measures in clinical and research settings as indicating such difficulties. And 
finally, the continuum of dysexecutive symptoms found in non-clinical groups, as well as 
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Section/topic  # Checklist item  
Reported 
on page # 
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  15 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key 
findings; systematic review registration number.  
16 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  17 to 22 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, 
and study design (PICOS).  
22 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration 
information including registration number.  
23 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale.  
24 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) 
in the search and date last searched.  
23 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.  23 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the 
meta-analysis).  
22 to 24 
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining 
and confirming data from investigators.  
23 to 24 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications 
made.  
24 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used in any data synthesis.  
25 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  24 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for 
each meta-analysis.  
25 
 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).  25 to 26 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.  n/a 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a 
flow diagram.  
26 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.  28 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  29 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect 
estimates and confidence intervals, ideally with a forest plot.  
31 to 40 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  41 to 49 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  30 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  n/a 
DISCUSSION   
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Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare 
providers, users, and policy makers).  
49 to 51 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting 
bias).  
51 to 55 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  55 to 56 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.  n/a 
 






Appendix C: Interpretation of psychometric properties (adapted based on Hermans 
et al. (2011)) 
 
Psychometric Statistic Interpretation 














Correlation Coefficients (Pearson’s 








Little or no correlation  
Low correlation  
Moderate correlation  
High correlation  
Very high correlation  



























Appendix D: Modified QUADAS-2 
 
DOMAIN 1: PARTICIPANT SELECTION  
A. Risk of Bias  
 Were selection criteria clearly described? (Yes/No/Unclear) 
 Was a consecutive or random sample of participants enrolled? (Yes/No/Unclear) 
 Did the study avoid inappropriate exclusions? (Yes/No/Unclear) 
Could the selection of participants have introduced bias? RISK: LOW 
/HIGH/UNCLEAR 
 
B. Concerns regarding applicability  
 
Is there concern that the included participants do not match the review question? 
CONCERN: LOW /HIGH/UNCLEAR 
 
 
DOMAIN 2: INDEX TEST(S) 
A. Risk of Bias 
 Was the execution of the index text described in sufficient detail to permit 
replication of the test? (including details of it being appropriately translated where 
applicable) (Yes/No/Unclear) 
Could the conduct or interpretation of the index test have introduced bias? RISK: 
LOW /HIGH/UNCLEAR 
 
B. Concerns regarding applicability 
 
Is there concern that the index test, its conduct, or interpretation differ from the 
review question? CONCERN: LOW /HIGH/UNCLEAR 
 
DOMAIN 3: REFERENCE STANDARD  
A. Risk of Bias  
 Is the reference standard likely to correctly classify the target condition? 
(Yes/No/Unclear/N/A) 
Could the reference standard, its conduct, or its interpretation have introduced bias? 
RISK: LOW /HIGH/UNCLEAR  
 
B. Concerns regarding applicability 
Is there concern that the target condition as defined by the reference standard does not 










DOMAIN 4: FLOW AND TIMING  
A. Risk of Bias  
 Was there an appropriate interval between index test(s) and reference standard? 
(Yes/No/Unclear/N/A) 
 Did all participants receive a reference standard? (Yes/No/Unclear/N/A) 
 Did participants receive the same reference standard? (Yes/No/Unclear/N/A) 
 Were all participants included in the analysis? (were withdrawals from the study 
explained?) (Yes/No/Unclear) 
 


















Appendix E: Quality Assessment using the QUADAS-2 
Table 1. 
Risk of bias and applicability ratings across domains for all included papers. 

















Beerten-Duijkers et al. 
(2019) 
U/C LOW LOW LOW LOW LOW LOW 
Bodenburg et al. (2008) LOW U/C N/A LOW LOW LOW N/A 
Caracuel et al. (2012) HIGH U/C N/A HIGH HIGH LOW N/A 
Carvalho et al. (2013) LOW U/C U/C U/C LOW LOW U/C 
Ciszewski et al. (2014) LOW LOW N/A U/C HIGH LOW LOW 
Coolidge et al. (1995) U/C U/C N/A U/C HIGH LOW U/C 
Dimitriadou et al. (2018) LOW LOW N/A LOW LOW LOW N/A 
Duggan et al. (2018) U/C U/C LOW U/C LOW LOW LOW 
Grace et al. (1999) LOW LOW LOW HIGH LOW LOW LOW 
Hauser et al. (2013) HIGH U/C HIGH HIGH LOW LOW HIGH 
Hellebrekers et al. (2017) LOW LOW LOW HIGH LOW LOW LOW 
Holst et al. (2017) HIGH LOW LOW U/C LOW LOW LOW 
Mani et al. (2018) LOW LOW HIGH U/C LOW LOW HIGH 
Milan et al. (2008) U/C LOW LOW LOW LOW LOW LOW 
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Miranda et al. (2019) U/C U/C N/A LOW LOW LOW N/A 
Niemeier et al. (2013) LOW U/C HIGH U/C LOW LOW HIGH 
Rouel et al. (2016) HIGH LOW LOW LOW LOW LOW LOW 
Shaw et al. (2015) HIGH LOW HIGH LOW LOW LOW HIGH 
Shinagawa et al. (2007) LOW LOW LOW LOW LOW LOW LOW 
Simblett et al. (2012) LOW U/C N/A U/C LOW LOW N/A 
Simblett et al. (2017) U/C LOW N/A U/C LOW LOW N/A 
Vélez-Pastrana et al. (2016) HIGH LOW HIGH U/C LOW LOW HIGH 
Velligan et al. (2002) HIGH LOW LOW HIGH LOW LOW LOW 
Waid-Ebbs et al. (2012) U/C LOW N/A U/C LOW LOW N/A 
Note. N/A = not applicable, U/C = unclear
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Appendix F: Reviewer agreement 
Table 2.  
A sample of the papers reviewed by a second reviewer in the systematic review 
  Author (H.W) Reviewer (P.M) 
Author & Title Include/Exclude Reason for exclusion Include/Exclude Reason for exclusion 
Badrkhahan et al. (2019) Exclude Not an EF measure Exclude Not on EF 
Dilandro (2008) Exclude Not an EF measure Exclude Not on EF 
Duggan et al. (2018) Include  Include  
Dukart et al. (2015) Exclude Not an EF measure Exclude Not on EF 
Fegyveres et al. (2008) Exclude Not an EF measure Exclude Not on EF 
Hauser et al. (2013) Include  Include  
Julayanont et al. (2015) Exclude Not an EF measure Exclude Not on EF 
Mani et al. (2018) Include  Include  
Manivannan et al. (2019) Exclude Not a rating scale measure Exclude No rating scale 
Niemeier et al. (2013) Include  Include  
Park et al. (2012) Exclude Only reports validity Exclude No reliability measure 
Rand et al. (2009) Exclude Not a rating scale measure Exclude Not a rating scale 
Simões (2012) Exclude 
Does not assess psychometrics 
of EF rating scales 
Exclude 
Review - not including EF 
rating scale 
van Beilen et al. (2005) Exclude Not a rating scale measure Exclude Test - Not a rating scale 
Velligan et al. (2002) Include  Include  
Waldon et al. (2016) Exclude Child sample Exclude Children 
Wang et al. (2017) Exclude Not an EF measure Exclude Not an EF rating scale 
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Viklund et al. (2019) Include  Include  
Winkens et al. (2009) Exclude Not an EF measure Exclude Not on EF 
Withrington et al. (2014) Exclude Only reports validity Exclude Not mentioning reliability 
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Appendix H: Participant Information Sheet  
 
Participant Information Sheet:  January 2019 Version 2 
 
Study Title: “Psychometric properties of the revised Dysexecutive Questionnaire (DEX-
R) in a non-clinical population” 
 
Thank you for your interest in this study which forms part of a Doctorate in Clinical 
Psychology thesis. Before you decide whether you would like to take part, please read the 
following information carefully. If you would like more information about the study, 
please do not hesitate to email me any questions.  
 
What is this research looking at?  
This research is looking at how we measure a particular set of mental abilities known as 
‘executive’ functions in the general population. These relate to thinking skills such as our 
memory, concentration, emotional regulation and motivation. There are variations between 
people in the general population, and it is this difference that the research is interested in. 
We already understand that difficulties in these mental abilities can be more pronounced 
for those who have a neurological illness or brain injury.  
 
Do I have to take part?  
If you want to take part, you will need to provide informed consent. This is your agreement 
that you have been given enough information about the study to help you decide whether 
or not to take part. You do not have to take part, and your participation is voluntary. 
 
What will happen if I agree to take part?  
First you must confirm that you are over 18 and that you speak English. You will then be 
asked to complete a consent form. You will then be asked to complete two questionnaires 
made up of 83 questions in total, and answer a few questions about you, all of which 
should take no longer than 30 minutes. We want to repeat one of the questionnaires a 
second time. After three weeks you will be emailed again to complete this. You will be 
given an online debrief which will address the aims of the study. You will also be provided 
with contact information for the researcher and supervisor should you want further 
information.  
 
Are there any problems with taking part?  
We do not think taking part will cause any difficulties or problems, other than requiring 
about half an hour of your time. Some people might have concerns about their thinking 
skills. These questionnaires cannot tell us if you have a particular health condition that 
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might affect thinking skills. Although the questions relate to challenges found in the typical 
population, if taking part does raise any questions or concerns, you should discuss this with 
your general practitioner.  
 
Will it help me if I take part?  
No, this study will not help you if you take part. Taking part in the study will add to our 
understanding of these types of mental skills in the general population and in people with 
health conditions involving the brain. 
 
How will you store the information that I give you?  
The information generated from this study will be strictly confidential and stored in 
accordance with the law on keeping information safe the General Data Protection Act. All 
data will be anonymous, and each person’s responses assigned a unique code to help 
identify it. Where your email is kept for communication purposes it will not be linked to 
your data in any way. All data will be kept in the custody of the research team at UEA. 
You will be assigned a unique code to maintain anonymity, this will ensure no data can be 
traced back to your name. Data will be archived for 10 years after the end of the study, 
after this period it will be securely destroyed. All electronic data will be stored on an 
encrypted USB and password protected computer. Data will only be accessed by the lead 
researcher and research team. We will only require an email address for distributing the 
project, no other personal identifiable information will be collected. 
 
How will the data be used?  
Data will be analysed and used for a trainee clinical psychologist as part of their thesis for 
completion of the Doctorate in Clinical Psychology (DClinPsy). It may be used for further 
analyses by members of the research team for example to compare scores against patients 
with brain injuries. 
 
What happens if I agree to take part, but change my mind later?  
Your participation is voluntary, and you are under no obligation to take part. You can 
withdraw at any time during completion of the survey, but after that, as the data is 
anonymous, we won’t be able to withdraw your data. If you ask to withdraw after 
completing the first set of questionnaires, then we will stop the email being sent reminding 
you to complete the second set of questionnaires.  
 
How do I know that this research is safe for me to take part in?  
The study has been reviewed by staff at UEA, the research team and has been approved by 




If you have any questions or concerns about this research, please contact the 
researchers or department.  
 
Questions regarding this research can be directed to the research team via: 
Researcher Contact details: Hannah Wakely: h.wakely@uea.ac.uk  
Supervisor: Dr Fergus Gracey: f.gracey@uea.ac.uk  
 
Concerns or complains about the research can be made through the Head of Department: 
Professor Niall Broomfield, Head of Department.  
Norwich Medical School 
Faculty of Medicine and Health Sciences 















Appendix I: Consent Form 
Consent Form:  January 2019 Version 2 
Study Title: “Psychometric properties of the revised Dysexecutive Questionnaire (DEX-
R) in a non-clinical population” 
Name of Researcher: Hannah Wakely  
Thank you for your interest in this study exploring psychometric properties of a measure of 
dysexecutive problems. The term ‘dysexecutive’ refers to variations in thinking skills such 
as our memory, concentration, emotional regulation and motivation. The following 
questionnaire is part of a research project by Hannah Wakely for a thesis research project 
as part of the Doctorate in Clinical Psychology.  
Your participation is voluntary, and you are free to withdraw at any time during 
completion of the survey without giving any reason and without it affecting you in any 
way.   
Your email address will not be shared outside of the research team or published in the final 
report(s) from this study.  
 
If you are interested in taking part, we would like you to confirm the following: 
 
I have read the preceding information describing this study   
 
I understand I am free to withdraw at any point by closing the survey window, but not once 
I have completed the survey   
 
I understand my anonymous data may be used by the research team in future research 
studies   
 
I am 18 years of age or older   
 








































































































Appendix M: Responses to health questions in the empirical paper 
Table 3. 





























1 (0.7)  
 
Neurodevelopmental 
Autism Spectrum Disorder 
Attention Deficit Disorder 
Learning disability 
Other 



































Appendix N: Frequency of responses on DEX-R items 
Table 4. 
DEX-R item distribution for time 1.  
Item Number and Description 
Frequency (%)  
(n = 125) 
Never Occasionally Sometimes Fairly often  Very often 
1. Impulsivity 32 (25.6) 59 (47.2) 29 (23.2) 5 (4.0) 0 (0) 
2. Prospective memory 32 (25.6) 59 (47.2) 24 (19.2) 6 (4.8) 4 (3.2) 
3. Apathy 32 (25.6) 57 (45.6) 24 (19.2) 11 (8.8) 1 (0.8) 
4. Initiation 21 (16.8) 56 (44.8) 29 (23.2) 15 (12.0) 4 (3.2) 
5. Planning 54 (43.2) 43 (34.4) 17 (13.6) 8 (6.4) 3 (2.4) 
6. Social disinhibition 28 (22.4) 65 (52.0) 21 (16.8) 9 (7.2) 2 (1.6) 
7. Intention 29 (23.2) 49 (39.2) 22 (16.6) 20 (16.0) 5 (4.0) 
8. Verbal aggression 3 (2.4) 38 (30.4) 47 (37.6) 33 (26.4) 4 (3.2) 
9. Verbal fluency 19 (15.2) 56 (44.8) 35 (28.0) 13 (10.4) 2 (1.6) 
10. Anger 36 (28.8) 62 (49.6) 19 (15.2) 7 (5.6) 1 (0.8) 
11. Perseveration 77 (61.6) 32 (25.6) 11 (8.8) 4 (3.2) 1 (0.8) 
12. Performance monitoring 57 (45.6) 57 (45.6) 11 (8.8) 0 (0) 0 (0) 
13. Abstract thinking 66 (52.8) 45 (36.0) 9 (7.2) 5 (4.0) 0 (0) 
14. Metaworry 44 (35.2) 48 (38.4) 17 (13.6) 12 (9.6) 4 (3.2) 
15. Lack of concern 57 (45.6) 34 (27.2) 20 (16.0) 13 (10.4) 1 (0.8) 
16. Blunted affect 1 60 (48.0) 42 (33.6) 16 (12.8) 6 (4.8) 1 (0.8) 
17. Working memory 40 (32.0) 53 (42.4) 23 (18.4) 6 (4.8) 3 (2.4) 
18. Lack of social composure 46 (36.8) 43 (34.4) 25 (20.0) 8 (6.4) 3 (2.4) 
19. Insight 86 (68.8) 27 (21.6) 7 (5.6) 4 (3.2) 1 (0.8) 
20. Inertia 44 (35.2) 54 (43.2) 16 (12.8) 8 (6.4) 3 (2.4) 
21. Temporal sequencing 80 (64.0) 32 (25.6) 8 (6.4) 5 (4) 0 (0) 
22. Cognitive control 33 (26.4) 59 (47.2) 14 (11.2) 16 (12.8) 3 (2.4) 
23. Variable motivation 72 (57.6) 36 (28.8) 12 (9.6) 4 (3.2) 1 (0.8) 
24. Physical aggression 102 (81.6) 17 (13.6) 3 (2.4) 2 (1.6) 1 (0.8) 
25. Organisational ability 45 (36.0) 42 (33.6) 21 (16.8) 14 (11.2) 3 (2.4) 
26. Inability to inhibit responses 53 (42.4) 57 (45.6) 7 (5.6) 7 (5.6) 1 (0.8) 
27. Confabulation 107 (85.6) 18 (14.4) 0 (0) 0 (0) 0 (0) 
28. Emotional lability 91 (72.8) 23 (18.4) 10 (8.0) 1 (0.8) 0 (0) 
29. Distraction 17 (13.6) 73 (58.4) 17 (13.6) 13 (10.4) 5 (4.0) 
30. Restlessness 52 (41.6) 51 (40.8) 18 (14.4) 4 (3.2) 0 (0) 
31. Cognitive confidence 53 (42.4) 56 (44.8) 14 (11.2) 1 (0.8) 1 (0.8) 
32. Knowing doing dissociation 68 (54.4) 46 (36.8) 9 (7.2) 2 (1.6) 0 (0) 
33. Blunted affect 2 57 (45.6) 49 (39.2) 12 (9.6) 7 (5.6) 0 (0) 
34. Information processing 76 (60.8) 28 (22.4) 14 (11.2) 7 (5.6) 0 (0) 
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35. No concern for social rules 75 (60.0) 31 (24.8) 14 (11.2) 5 (4.0) 0 (0) 
36. Complex attention 44 (35.2) 59 (47.2) 14 (11.2) 8 (6.4) 0 (0) 





















Appendix O: Means, Standard Deviations and Interquartiles   
Table 5.  
Means, Standard Deviations and Interquartiles for all questionnaires 
                                                                                                      Interquartile 
 Mean S.D 25 50 75 
DEX-R, time 1 
DEX-R, time 2 
FrSBe  
GAD-2 
PHQ-2 
33.06 
35.95 
82.77 
1.55 
0.92 
17.80 
20.05 
19.41 
1.53 
1.37 
19.50 
21.00 
69.75 
0.00 
0 
30.00 
28.50 
77.50 
1.00 
0 
42.00 
47 
93.50 
2.00 
1.25 
 
 
